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ABSTRACT 
Acceptance and Commitment Therapy for Psychiatric Inpatients  
with Psychotic Symptoms 
Brandon A. Gaudiano 
James D. Herbert, Ph.D. 
 
 
 
Cognitive behavior therapy has been demonstrated in a number of randomized controlled 
trials to be efficacious for the treatment of psychosis.  Emerging evidence suggests the 
usefulness of related mindfulness/acceptance-based approaches for this population.  The 
current study was designed to replicate and extend previous findings by Bach and Hayes 
(2002).  Psychiatric inpatients with psychotic symptoms were randomly assigned to 
enhanced treatment as usual or enhanced treatment as usual plus individual sessions of 
Acceptance and Commitment Therapy (ACT).  Results revealed greater improvements in 
the ACT group at post-treatment on clinician-rated affective symptoms and global 
improvement, and self-rated distress associated with hallucinations and impairment in 
social functioning.  Overall large effect size improvements were demonstrated in both 
groups pre- to post-treatment, with medium effect sizes differences between groups 
favoring the ACT condition.  In addition, significantly more participants in the ACT 
condition reached clinically significant improvements in overall symptoms at post-
treatment.  At 4-month follow-up, 45% of participants in the ETAU only group had been 
rehospitalized compared to only 28% of those in the ACT group.  Results suggested that 
believability in hallucinations mediated the relationship between symptom frequency and 
distress.  Improvement in believability of hallucinations over time was only observed in 
the ACT condition, and change in believability predicted change in associated distress 
after controlling for change in frequency of hallucinations.  Results are viewed as largely 
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consistent with the findings of Bach and Hayes and warrant future investigations with 
larger samples.  Future research should continue to investigate possible mechanisms of 
action in effective psychosocial treatments for psychosis. 
 
 
1 
1. INTRODUCTION 
 
 Even with advances in pharmacological treatments, schizophrenia and other 
psychotic disorders are typically chronic and debilitating conditions (Pratt & Mueser, 
2002).  Many patients continue to experience residual symptoms and related problems 
associated to these disorders even when treatment compliance is not an issue.  Research 
suggests that between 25 and 60 percent of patients who adhere to drug treatment 
continue to experience psychotic symptoms (Curson, Patel, Liddle, & Barnes, 1988).  
Furthermore, 25 to 40 percent of individuals who experience psychosis often exhibit 
comorbid mood and anxiety symptoms (Johnstone, Owens, Frith, & Leavy, 1991).  The 
experience of positive symptoms is one of the best predictors of rehospitalization 
(Tarrier, Barrowclough, & Bamrah, 1991).  Therefore, the development of efficacious 
and effective adjunctive psychosocial treatments is imperative for treating psychotic 
patients.  The proposed study attempted to evaluate the impact of using a newer 
psychosocial intervention to treat the symptoms associated with psychotic disorders. 
1.1. Cognitive Behavior Therapy for Psychotic Disorders 
Over the past decade, cognitive behavior therapy (CBT) has been found in a 
number of randomized clinical trials to be efficacious for the treatment of schizophrenia 
and related psychotic disorders (Beck & Rector, 2000).  Originally developed for the 
treatment of depression and anxiety in the 1960s and 70s primarily by Beck and 
colleagues (1979) and Ellis (1962), CBT focuses on the modification of dysfunctional 
beliefs to promote affective and behavior change.  In the intervening years, CBT has been 
adapted successfully for a diverse array of psychiatric conditions, including substance 
abuse, bulimia nervosa, personality disorders, and disorders of childhood/adolescence 
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(Salkovskis, 1996).  However, only recently has substantial attention been directed 
toward adapting CBT for patients with psychotic disorders.  Perhaps this is because the 
prevailing wisdom in the mental health field traditionally has been that patients who 
experience delusions and hallucinations are not amenable to “talk therapy” (Jaspers, 
1963).  Furthermore, early studies of traditional psychotherapy (i.e., psychoanalytic 
approaches) with these patients generally reported negative outcomes (McGlashan, 
1994).   
 In contrast to traditional psychodynamic therapies, newer psychosocial 
approaches with empirical support are structured, symptom-focused, and goal-oriented.  
Although no one specific CBT protocol has been used predominantly with this 
population, most studies have employed a treatment package that includes several core 
elements.  Kingdon and Turkington (1994) describe a comprehensive CBT approach for 
treating psychosis that provides a representative example.  First, a rationale for treatment 
is provided through patient education about psychotic symptoms and diagnoses.  Next, 
the antecedents of psychotic episodes are identified and the interaction between thoughts 
and behaviors is highlighted.  Typically, comorbid mood and anxiety problems are 
treated first through standard cognitive-behavioral techniques (i.e., cognitive 
restructuring and behavioral activation or exposure).  Once a strong rapport has been 
built, patients are taught “reality testing” skills for dealing with positive symptoms such 
as delusions and hallucinations.  For example, after irrational thoughts about 
hallucinations are delineated, behavioral experiments are conducted to examine the 
validity of the belief.  Later sessions focus on cognitive-behavioral techniques for 
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tackling negative symptoms (e.g., social skills training) and preventing relapse after 
discharge.   
1.2. Treatment of Outpatients 
Cognitive and behavioral techniques for treating delusions (e.g., Watts, Powell, & 
Austin, 1973) and hallucinations (e.g., Haddock, Slade, Bentall, Reid, & Farager, 1988) 
have been reported in the literature for decades, mostly in the form of case studies or 
uncontrolled trials.  Over fifty years ago, Beck (1952) reported on the successful 
cognitive treatment of a patient with treatment-resistant delusions.  Based on this early 
success, Hole, Rush, & Beck (1979) treated eight delusional patients with cognitive 
therapy and reported positive results.  Unfortunately, these early reports were devoid of 
experimental controls and thus provided little support for the systematic use of CBT with 
this population.   
1.2.1. Clinical trials with outpatients.  Tarrier and colleagues (1993) conducted 
one of the first methodologically rigorous clinical trials of CBT to treat the psychotic 
symptoms associated with schizophrenia.  All patients were stable on neuroleptic 
medications but still experiencing psychotic symptoms at the time of the study.  
Participants were randomly assigned to either a cognitive-behavioral treatment that taught 
active coping techniques for dealing with psychotic symptoms or a comparison condition 
that trained patients in general problem-solving skills.  Both treatments were compared to 
a wait-list control condition.  Results indicated that both active treatments were 
associated with improvement in psychotic symptoms compared to the wait-list condition 
at post-treatment, with patients maintaining gains at 6-month follow-up.  Although some 
evidence showed that the active coping treatment was superior to the general problem-
 
4 
solving condition, results were largely equivocal.  A major drawback of the study was 
that assessors were not blind to group allocation. 
Two more recent randomized controlled trials further point to the efficacy of CBT 
for psychotic symptoms.  Tarrier et al. (1998) randomly allocated participants with 
chronic schizophrenia to CBT and routine care (CBT-RC), supportive counseling and 
routine care (SC-RC), or routine care only (RC).  Assessors were blind to treatment 
condition and standardized symptom measures were used.  At post-treatment, a 
significant improvement in positive symptoms was demonstrated for those receiving 
CBT-RC, but not SC-RC or RC; CBT-RC was significantly better than RC.  At 3-month 
follow-up, those receiving RC showed greater relapse rates compared to those in the 
other two conditions.  At 12-month follow-up, CBT showed similar superiority to RC and 
some benefits over SC-RC (Tarrier, et al., 1999).  At 2-year follow-up, there were no 
differences between SC and CBT, although both were superior to RC alone (Tarrier et al., 
2000).   
In an effort to better control for nonspecific effects, Sensky et al. (2000) 
conducted a randomized controlled trial comparing CBT with a specially-designed 
nonspecific “befriending” comparison treatment.  Assessors were blind to treatment 
condition, and results revealed that both interventions resulted in significant reductions in 
positive and negative symptoms at post-treatment with no group differences.  However, 
at 9-month follow-up, those who received CBT demonstrated sustained improvement, 
whereas those in the comparison condition did not.   
1.2.2. Summary and conclusions.  Several other controlled trials have reported 
similar positive results using CBT to treat psychotic disorders in outpatients (e.g., 
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Durham et al., 2003; Garety, Kuipers, Fowler, Chamberlain, & Dunn, 1994; Kuipers et 
al., 1997; Pinto, La Pia, Mennella, Giorgio, & DeSimone, 1999; Rector, Seeman, & 
Zegal, 2003; Turkington, Kingdon, & Turner, 2002).  Over recent years, numerous 
qualitative reviews of the literature on CBT for psychosis have been written (e.g., Beck & 
Rector, 2000; Bouchard, Vallieres, Roy, & Maziade, 1996; Gaudiano, in press; Henriques 
& Beck, 2000; Mueser, Bond, & Drake, 2001).  Furthermore, other authors have written 
about CBT case formulation and treatment implementation specifically for psychotic 
disorders (e.g., Haddock & Tarrier, 1998; Kingdon, 1998; Kingdon & Turkington, 1994; 
Levine, Barak, & Caspi, 1995; Rector & Beck, 2002).  The adaptation and 
implementation of CBT to treat the residual symptoms or as management treatment for 
outpatients with psychotic disorders is amassing a considerable amount of empirical 
support.  Nevertheless, numerous lingering empirical questions remain.  For example, the 
methodological rigor of previous studies varies considerably, and none have compared 
CBT to another empirically supported treatment for schizophrenia or related disorders 
(e.g., family therapy).  Furthermore, CBT protocols include multiple cognitive and 
behavioral interventions that often differ between studies, hampering comparisons of 
trials. 
1.3. Treatment of Acute Psychotic Episodes 
 Effective psychosocial treatments may be especially important to implement in 
the acute phase of psychosis.  For example, Shepherd, Watt, Falloon, & Nigel (1989) 
conducted a 5-year follow-up of schizophrenic patients, and found that for a third of the 
sample, increased impairment in functioning and residual symptoms occurred after each 
acute psychotic episode.  Therefore, it is important to identify treatments that could 
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shorten the length of acute psychosis and also lengthen the time between episodes.  
Unfortunately, there is a paucity of research on effective psychosocial treatments for 
psychotic inpatients in the acute phase of their illness.   
1.3.1. Clinical trials with inpatients.  Most of the previous research reviewed on 
CBT for psychosis used outpatient samples.  Bazzoni, Morosini, Polidori, Rosicarelli, and 
Fowler (2001; see description below) conducted an uncontrolled study that supported the 
effectiveness of CBT for psychosis in an inpatient sample.  However, only two known 
controlled trials have been conducted examining CBT exclusively for inpatients.  In an 
early trial, Milton, Patwa, and Hafner (1978) randomly assigned inpatients with delusions 
to 5 weeks of either a confrontation (i.e., direct confrontation of the patient’s delusional 
beliefs) or a belief modification (i.e., gentle questioning and seeking alternative 
interpretations for beliefs) group treatment.  They found a significant decrease in the 
strength of delusional beliefs from pre-treatment to 6-week follow-up in the belief 
modification but not the confrontation condition.   
In a more rigorous examination, Dury and colleagues (1996a) randomly assigned 
40 inpatients to either individual and group CBT plus routine care or supportive therapy 
plus routine care for 12 weeks.  Both groups showed improvement throughout treatment, 
although patients receiving CBT showed superior change on an index of positive 
symptoms and delusional conviction compared to those receiving supportive therapy.  
Furthermore, the differences between conditions were observable by 6 weeks of 
treatment.  These results were maintained at 6-month follow-up, with those receiving 
CBT showing a faster time to recovery compared to those receiving supportive therapy 
(Dury, et al. 1996b).  Dury, Birchwood, and Cochrane (2000) reported on a 5-year follow 
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up of the sample.  Overall, they found that the two groups were comparable in terms of 
outcome; however, when results were examined on a subsample of patients who relapsed 
a maximum of one time, observer-rated hallucinations and delusions were significantly 
lower in the CBT compared to the recreational therapy group.  Results are limited 
because assessors were not blind to treatment condition. 
In an attempt to decrease subsequent psychotic episodes in those recently 
diagnosed, Lewis et al. (2002) randomly assigned 315 inpatients during their first or 
second hospital admission to CBT plus routine care, supportive counseling plus routine 
care, or routine care alone.  Those in the CBT condition received 5 weeks of intensive 
therapy (15-20 hours) and booster sessions over the following 3 months, which began 
during the inpatient stay and continued after discharge.  Those in the CBT condition 
showed a faster rate of improvement.  However, CBT produced only early, transient 
benefits over the other conditions that were lost at later time points.  At 18-month follow-
up, no differences were observed between CBT and supportive counseling (Tarrier et al., 
2004). 
1.3.2. Summary and conclusions.  The results of the studies by Bazzoni et al. 
(2001), Lewis et al. (2002), Milton et al. (1978), and Dury and colleagues (1996a, 1996b, 
2000) suggest that CBT delivered to inpatients can provide significant improvements 
over other treatments.  Due to the relative paucity of studies with inpatient samples, the 
proposed study will be conducted on an inpatient unit with individuals who are 
hospitalized for an acute psychotic episode.  A promising new psychosocial treatment 
will be investigated that—as compared to previous studies—is especially feasible to 
deliver in an inpatient setting.  Previous trials, including those of Tarrier et al. (1998) and 
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Sensky et al. (2000), used more intensive, long-term formats, which may be difficult to 
implement in practice.  The current study will use a relatively brief treatment format. 
1.4. Effectiveness Research   
The studies discussed above primarily were efficacy trials that examined the 
benefit of CBT for psychosis under controlled conditions in order to draw causal 
inferences.  They usually included random assignment to conditions, adherence to strict 
treatment protocols, and stringent inclusion/exclusion criteria.  However, the growing 
consensus in the field of outcome research is that efficacy studies should attempt to more 
specifically address the problems faced by practicing clinicians (Seligman, 1995).  
Therefore, effectiveness research generally uses naturalistic or observational designs for 
assessing treatment outcome in typical clinical settings with a wider range of patients.   
1.4.1. Effectiveness trials.  Bazzoni et al. (2001) tested the effectiveness of CBT 
for schizophrenia.  These researchers used a group CBT approach with inpatients 
hospitalized for acute psychosis in Italy.  They compared hospital records on indices such 
as rehospitalization rates, use of physical restraints, and escape behavior on the unit 
before and after providing the CBT intervention to 385 patients.  They reported that 
rehospitalization rates decreased by a third, violent episodes declined by almost half, and 
patient escape attempts nearly disappeared after CBT treatment.  Furthermore, patients 
expressed high satisfaction with the CBT group.  Unfortunately, because no experimental 
controls were employed, it is impossible to conclude with certainty that the 
improvements observed were specifically attributable to the CBT intervention.  However, 
results do demonstrate that CBT can be successfully integrated into inpatient treatment.     
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Furthermore, Wiersma and colleagues (2001) reported that 60% of 40 patients 
with treatment refractory auditory hallucinations showed significant improvements in 
symptoms over 4-years of a naturalistic treatment study.  Jakes, Rhodes, and Turner 
(1999) found that one-third of 18 patients with chronic delusions responded to cognitive 
therapy in terms of positive changes in believability of delusions, although all patients 
maintained some degree of belief in delusions at post-treatment.   
1.4.2. Summary and conclusions.  Researchers have recommended that future 
trials more closely determine the effectiveness—or real-world benefit—of the treatment.  
Although Bazzoni et al. (1995) investigated the effectiveness of delivering CBT for 
psychosis, the lack of experimental controls in the study precluded definitive conclusions.  
Clarke (1995) argued for the development and use of alternative methodologies that keep 
experimental controls while also addressing effectiveness concerns.  Therefore, the 
proposed study will seek to incorporate important aspects of effectiveness trials, while 
retaining the necessary elements of efficacy research (e.g., random assignment and 
manualized treatment).  Previous trials, including those of Tarrier et al. (1998) and 
Sensky et al. (2000), used more intensive, long-term individual formats, which may be 
difficult to implement in practice.  The current study will use a relatively brief treatment 
that can be more easily implemented in psychiatric treatment settings.  Therefore, the 
current study will incorporate several elements of efficacy and effectiveness trials that 
have never been achieved in other studies in this area. 
1.5. Meta-Analytic Conclusions   
To date, four meta-analytic reviews have examined the efficacy of CBT for 
schizophrenia.  An early Cochrane Review (Jones, Cormac, Mota, & Campbell, 1998) 
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based on four small trials concluded that the treatment may be effective in reducing 
relapse rates but questioned its superiority to other treatments.  These reviewers argued 
for the development of CBT protocols that could be implemented by less experienced 
therapists.  More recently, Rector and Beck (2001) conducted a meta-analysis of seven 
randomized-controlled trials and computed effect size estimates based on comparisons of 
CBT to a control condition.  They found large effects for CBT on positive and negative 
symptom measures and additional benefits for CBT over routine care and supportive 
psychotherapy.  Large effect size gains were identified once again for CBT on psychotic 
symptom measures in a meta-analysis conducted by Gould, Mueser, Bolton, Mays, & 
Goff (2001).  Furthermore, follow-up analyses suggested that patients receiving CBT 
continued to improve post-treatment.   Most recently, Pilling and colleagues (2002) 
conducted a meta-analysis on a total of 14 CBT trials, and concluded that CBT 
interventions produced clinically significant reductions in symptoms and improvements 
on continuous measures through follow-up.    
The present study will seek to extend the findings of previous research in this area 
by investigating the efficacy of a relatively novel form of CBT for psychotic disorders 
that incorporates elements of mindfulness and acceptance (explained below).  Both Beck 
and Rector (2001) and Gould et al. (2001) recommended that future research examine 
more closely the benefit of CBT in decreasing rehospitalization rates.  The present study 
will examine rehospitalization rates at 4-month follow-up to determine if CBT added to 
routine care results in decreased relapse rates compared to routine care alone.  As 
recommended by Gould et al., the sample in the current study will include many 
participants who are of minority status and who possess comorbid psychiatric and 
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medical conditions.  The inclusion of participants with diverse demographic 
characteristics helps to ensure external validity or generalizability of results to typical 
settings.   
1.6. Mindfulness/Acceptance-Based Approaches for Psychotic Disorders 
 CBT traditionally focuses on the active disputation and modification of 
dysfunctional beliefs to decrease their frequency, intensity, and believability.  Newer 
cognitive-behavioral approaches have explored the addition of mindfulness/acceptance 
techniques that target symptoms without directly seeking to change their content.  Some 
have described mindfulness/acceptance approaches as the “third wave” of behavior 
therapy, with the first wave denoting traditional behavior therapy, and the second 
representing cognitive therapy (Hayes, in press).  Such techniques have been adapted for 
treating a variety of difficult problems:  Borderline Personality Disorder (Linehan, 
Armstrong, Suarez, & Allmon, 1991; Linehan, Heard, & Armstrong, 1994), couples 
discord (Jacobson, Christensen, Prince, Cordova, & Eldridge, 2000), Generalized 
Anxiety Disorder (Roemer & Orsillo, 2002), pain tolerance (Rosenfarb, Cooper, & 
Grundy, 1999), relapse prevention in Major Depression Disorder (Teasdale, et al., 2000), 
substance abuse (Marlatt, 2002), and trauma (Follette, 1994).  Although definitions of 
mindfulness vary widely, put simply the term means “paying attention in a particular 
way:  on purpose, in the present moment, and nonjudgmentally” (Kabat-Zinn, 1994, p. 3).  
The aim of mindfulness/acceptance strategies is to help individuals “de-fuse” from 
internal sources of distress (e.g., negative thoughts or emotions), not though continued 
avoidance or disputation of these disturbing feelings, but through an adopted stance of 
acceptance and mindfulness.   
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Although the inclusion of mindfulness/acceptance techniques may appear 
inconsistent with CBT, emerging evidence suggests that the development of a 
mindfulness stance may in fact mediate treatment response in traditional CBT.  Teasdale 
and colleagues (2002) examined the metacognitive awareness (i.e., the degree to which 
individuals experience negative thoughts/feelings as mental events rather than as the self) 
of treatment responders to traditional cognitive therapy and to mindfulness-based 
cognitive therapy for depression.  They found that increased metacognitive awareness 
predicated reduced relapse rates in both treatment approaches.  A recent study by 
Sheppard and Teasdale (2004) showed that metacognitive awareness mediated the 
relationship between dysfunctional thinking and remission to Major Depression in 
contrast to decreased access to dysfunctional schemas. 
 1.6.1. Acceptance and Commitment Therapy.  To date, the most comprehensively 
formulated mindfulness/acceptance-based cognitive behavior therapy is Acceptance and 
Commitment Therapy (ACT; Hayes, Strosahl, & Wilson, 1999).  Blackledge and Hayes 
(2001) summarize the approach as follows:  “Stated simply, the ACT model of 
psychopathology holds that a great deal of our difficulties comes from fusion with 
cognitions (i.e., believing that a thought that interprets experience is actually true) and 
resultant experiential avoidance that disrupts or impedes movement toward valued goals” 
(p. 246).  In contrast to avoiding or struggling with negative thoughts and emotions, ACT 
is designed to help individuals accept and experience symptoms nonjudgmentally, while 
simultaneously working toward the pursuit of valued behavioral goals.  This stance is 
achieved primarily through the use of experiential exercises (e.g., meditation) and 
didactic metaphors, and is presented in the context of values clarification, goal setting, 
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and overt behavior change strategies.   Patients are taught to abandon control-oriented 
strategies aimed at controlling unpleasant private experiences, and instead to accept the 
presence of distressing symptoms while learning to notice nonjudgmentally the 
occurrence of thoughts, feelings, and sensations without assuming that they are literally 
“true.”  Acceptance does not imply “giving in” to symptoms, but instead recognizes that 
thoughts are products of mental events rather than the self.   
Preliminary evidence suggests that ACT produces improvements that are at least 
as robust as those observed with disputation-based CBT in a variety of populations (see 
Hayes et al., 2004, for a review).  For example, Block (2002) found that those receiving 
both ACT and traditional group CBT significantly improved their public speaking 
anxiety.  Bond and Bunce (2000) found that both treatments were effective in reducing 
worker stress and anxiety.  However, results of both studies suggested that those 
receiving ACT showed greater acceptance of negative emotions compared to those 
receiving traditional CBT.  Furthermore, an effectiveness trial of ACT demonstrated its 
broad clinical usefulness in clinical practice (Strosahl, Hayes, Bergan, & Romano, 1998).  
Therapists were provided brief training in ACT and outcomes in a heterogeneous clinical 
sample were compared with those of therapists who did not receive the training.  Clients 
with ACT-trained therapists reported better coping and were more likely to have 
completed treatment compared to those of therapists not trained in ACT. 
1.6.2. ACT for psychosis.  Emerging evidence suggests the usefulness of 
mindfulness-based CBT for treating psychotic symptoms.  The philosophy underlying 
these treatments has even appeared in the popular media recently in the 2002 Academy-
Award winning film, A Beautiful Mind (Stone, 2002).  The film is based on the biography 
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of Nobel-prize winning mathematician John Nash, who uses aspects of mindfulness and 
acceptance to cope with his life-long struggle with schizophrenia (Nasar, 1998).   
In the professional literature, Garcia and Perez (2001) presented a case study 
describing the successful treatment of a patient with auditory hallucinations using ACT.  
However, Bach and Hayes (2002) conducted the first controlled trial using a 
mindfulness-based CBT for treating the psychotic symptoms associated with 
schizophrenia and related disorders.  Eighty patients were randomly assigned to TAU or 
TAU plus 4 individual sessions of ACT during inpatient and outpatient care.  Patients 
were taught to accept unavoidable events, to notice psychotic symptoms without treating 
them as either true or false, and to identify and work toward valued goals despite their 
symptoms.  Patients supplied simple Likert-scale ratings of the frequency, distress, and 
believability associated with their hallucinations and delusions pre-treatment and at 
follow-up, which included rehospitalization data.  Those receiving ACT demonstrated 
significantly higher reporting of, but lower believability in symptoms compared to the 
TAU only group.  The rehospitalization rate in the ACT group was only half that of the 
TAU only group at follow-up.   
Results of the Bach and Hayes (2002) study are promising, and some suggest that 
mindfulness-based CBT may have specific advantages over disputation-based CBT 
(Teasdale et al., 2002).  Researchers have warned that when using CBT with patients 
experiencing psychosis, it is important first to build a strong therapeutic alliance, and 
then to keep disputation to a minimum when engaging in cognitive restructuring (i.e., 
identifying and modifying distortions in thinking) (Kingdon & Turkington, 1994).  
Providing some empirical support for this suggestion, Milton et al. (1978) found that the 
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use of direct disputation techniques resulted in poor treatment outcome.  However with 
mindfulness-based CBT, the emphasis is not on disputing the literal truth of specific 
delusions or hallucinations, which can inadvertently result in alienating patients from 
treatment.  Instead, patients practice experiential exercises to help them experience their 
thoughts as the products of mental events and not the self, thereby loosening the 
association between internal feelings and external experience.  Patients often experience 
high levels of anxiety and depression related to psychotic symptoms (Harkavy-Friedman, 
Nelson, Venarde, Mann, 2004).  Although many patients experience distress associated 
with the psychotic symptoms themselves (e.g., hearing a disparaging voice), others may 
experience distress associated with the consequences of their psychotic symptoms (e.g., 
involuntary commitment due to safety concerns stemming from delusional thinking), 
depending on their level of insight.  ACT addresses both of these potential concerns, as 
the focus is not on the veracity of thoughts/symptoms, but the workability (or 
unworkability) of behaviors that result from buying into symptoms.  Therefore, patients 
are taught how to accomplish the goals that they set for themselves without getting side-
tracked by the struggle to eliminate psychotic symptoms.   
1.6.3. Summary and conclusions.  Results of the Bach and Hayes (2002) study 
suggest that brief acceptance/mindfulness-based CBT can provide important benefits to 
inpatients.  The proposed study will attempt to replicate and extend these findings.  For 
example, the previous study used simple, non-standardized assessments of psychotic 
symptoms.  The current study will use established and psychometrically sound symptom 
measures (e.g., Brief Psychiatric Rating Scale; Lukoff, Nuechterlein, & Ventura, 1986), 
along with self-report indices similar to those used by Bach and Hayes.  The current 
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study will use established and psychometrically sound symptom measures (e.g., The 
Brief Psychiatric Rating Scale; Lukoff, Nuechterlein, & Ventura, 1986), along with self-
report indices similar to those used by Hayes and Bach.  Furthermore, treatment will be 
provided to a more ethnically and demographically diverse sample compared to the Bach 
and Hayes study.  Additional treatment was a possible confound in the Bach and Hayes 
study, as patients were receiving ACT sessions beyond TAU.  In order to lessen the effect 
of this factor, patients will receive individual ACT sessions in place of one of the other 
TAU psychosocial elements of their treatment (i.e., routine group or individual therapy 
provided on the unit).  Finally, psychiatric inpatient length of stay in the current 
environment of managed-care is typically very brief.  In order to investigate real-world 
effectiveness, treatment was delivered in up to 5 sessions as appropriate based on length 
of stay on the unit.  As it often is difficult or impossible to provide continuity of care 
from inpatient to outpatient settings, treatment will be provided only for the duration of 
hospitalization, in contrast to the outpatient treatment provided by Bach and Hayes. 
1.7. Preliminary Research 
 The author and colleagues conducted a small pilot project assessing the 
effectiveness and feasibility of short-term cognitive-behavioral treatment for psychosis 
(Gaudiano, Osman, Boylan, & Herbert, 2001).  Participants were six adults diagnosed 
with psychotic disorders who were receiving standard partial hospitalization treatment, 
which included psychotropic medication and psychoeducational group and individual 
therapy at a community mental health center.  CBT was delivered by the first author and 
another clinical psychology doctoral student using a modified treatment protocol by 
Granholm, McQuaid, and McClure (2000).  The treatment consisted of a total of 12 
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weekly group sessions, and included education about psychotic symptoms and training in 
cognitive restructuring, social skills, and problem solving.  Acceptance of the experience 
of psychotic symptoms was stressed from a functional perspective.  Patients completed 
an average of 6 sessions and one patient dropped out of treatment at the program because 
of insurance reimbursement problems.  Several validated self-report measures were 
administered pre- and post-treatment (see Table 1).   
Analyses using non-parametric tests revealed that patients reported significant 
reductions in impairment following treatment and a marginally significant decrease in 
depressed mood.  A modified version of the Automatic Thoughts Questionnaire (Hollon 
& Kendall, 1980) was used that assessed both the frequency and believability of irrational 
beliefs.  Interestingly, results indicated that the believability but not the frequency of 
negative cognitions decreased after treatment.  In other words, whereas the frequency and 
believability of negative cognitions were nearly equivalent at pre-test, a significant 
reduction in the believability but not the frequency of these thoughts was found at post-
treatment.  One possible interpretation is that although participants were still 
experiencing negative cognitions, they believed less in the validity of these thoughts after 
treatment, similar to the findings of Bach and Hayes (2002).  Furthermore, patients 
reported positive reactions and high satisfaction with the treatment.  Although the amount 
of actual treatment time was minimal in most cases, other therapists from the program 
reported that patients would discuss and use the techniques and concepts from the CBT 
group in other groups.  The investigation had several limitations that precluded definitive 
conclusions about the effectiveness of CBT for psychotic patients, including small 
sample size, lack of independent measures of improvement, and lack of a comparison 
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group.  However, the data suggested that CBT could be efficiently delivered for a limited 
duration as an adjunctive treatment for serious mental illness using less experienced 
therapists.   
1.8. Summary and Study Rationale 
 Although the development of the newer atypical neuroleptics has produced 
revolutionary advancements in the treatment of psychotic disorders, many patients 
continue to experience both positive and negative symptoms even when medication 
compliance is not an issue.  Therefore, psychosocial treatments with substantiated 
efficacy and effectiveness that can be used in conjunction with pharmacotherapy are 
greatly needed.  Studies have demonstrated that cognitive behavior therapy (CBT) can be 
successfully adapted for treating psychotic disorders, including schizophrenia (Beck & 
Rector, 2000).  Furthermore, recent data suggest that CBT may prove more efficacious 
than supportive psychotherapy for schizophrenia (Tarrier, et al., 1998; Sensky et al., 
2000).   Acceptance and Commitment Therapy, a newer CBT approach that emphasizes 
mindfulness and acceptance, shows promise for treating psychosis (Bach & Hayes, 
2002), but requires further study and independent replication. 
 The current study incorporated elements of efficacy and effectiveness trials to 
examine a mindfulness-based CBT for treating inpatients with psychotic symptoms.  
First, most trials of CBT for this population have utilized efficacy instead of effectiveness 
designs, when the latter can better speak to the clinical benefits of a treatment in typical 
settings.  Therefore, the psychosocial treatment in the current study was delivered in a 
flexible individual format, with treatment length varying as a function of length of stay.  
Second, rehospitalization rate, which has been rarely assessed in previous research, was 
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examined in the current study.  Third, the psychosocial treatment used in the current 
study was delivered exclusively during hospitalization.  Fourth, a cognitive-behavioral 
treatment emphasizing aspects of mindfulness and acceptance was employed.  This type 
of therapy may be particularly advantageous as a brief treatment for use with patients 
with psychosis, as it emphasizes coping with chronic and treatment-resistant symptoms.  
Although preliminary research in this area is promising, there exists a crucial need for 
more controlled trials to determine the feasibility and effectiveness of treatment for this 
population.   
  The specific aims of the project were as follows:  1) to evaluate the additional 
efficacy of a newer psychosocial treatment in a controlled, longitudinal clinical trial of 
acute psychosis compared to standard treatment; 2) to measure treatment outcome in a 
multi-modal fashion, including self-report, clinician ratings, and objective indices (i.e., 
rehospitalization rates); 3) to examine psychological factors (e.g., believability in 
psychotic symptoms) as potential predictors of treatment response; and 4) to integrate 
efficacy and effectiveness design elements to ensure applicability to typical clinical 
settings.     
Therefore, the overall goal of the current study was to determine the efficacy of 
incorporating a mindfulness-based cognitive behavior therapy compared to treatment as 
usual for individuals hospitalized with severe mental illness.  In order to replicate and 
extend previous research in this area, patients currently hospitalized with a psychotic 
disorder were randomly assigned to either enhanced treatment as usual (ETAU) or ETAU 
that included individual sessions of ACT.  To better control for extra-treatment effects, 
patients in the ETAU only condition received milieu treatment (i.e., group/individual 
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session) in place of individual ACT sessions.  ETAU consisted of psychopharmacology 
and psychoeducational-supportive therapy in group and individual formats.  ACT 
employed patient education, goal setting, and mindfulness/acceptance-based techniques 
to help patients cope with psychotic symptoms.  The study was conducted within a 
multidisciplinary setting designed to integrate biological and psychosocial treatment of 
the illness.   
 Specific hypotheses for the study included:  1) Participants in the ACT condition 
would demonstrate greater improvements in outcomes compared to those receiving 
ETAU only.  2) ACT would produce lower relapse rates at 4-month follow-up compared 
to TAU only.  3) Believability would mediate the relationship between frequency of 
hallucinations and associated distress; and change in believability would predict change 
in distress, particularly for the ACT group. 
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2. METHODS 
2.1. Participants 
 Participants were referred by the supervising psychologist at Hahnemann 
University Hospital in Philadelphia, which houses a 20-bed inpatient acute 
psychiatric/medical care unit.  Patient stay is an average of 1week on the unit.  A total of 
42 adults currently hospitalized with a psychiatric illness participated in the study.  
Participants met DSM-IV (APA, 1994) criteria for a psychotic disorder or mood disorder 
with psychotic symptoms that required hospitalization based on the intake interview 
conducted by the treating psychiatrist.   
 The inclusion criteria for the study were:   
1. Patient hospitalized with current or recent (within past week) psychotic symptoms 
(hallucinations and/or delusions) and other severe psychopathology (including 
suicidality); 
2. Diagnosis of psychotic disorder or psychotic-spectrum disorder, including 
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Delusional 
Disorder, Brief Psychotic Disorder, Psychotic Disorder NOS, Major Depression with 
Psychotic Features (Other comorbid Axis I and Axis II disorders permitted), or other 
severe psychopathology with psychotic features that requires hospitalization, such as 
Bipolar Disorder; 
3. Fluency in English; 
4. Ability to provide informed consent; 
5. Ability to participant in psychotherapy. 
 The exclusion criteria were:   
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1. Documented diagnosis of Mental Retardation; 
2. Inability to participate due to acute medical condition or florid psychosis; 
3. Symptoms due to a general medical condition; 
4. Patient stay on the unit known in advance to be less than l week. 
Patient diagnoses sometimes change from intake to discharge when additional 
information becomes known.  Therefore, participants were excluded from analyses if new 
information over the course of their involvement in the study became known that affected 
their ability to meet inclusion/exclusion criteria.   
With some participants, it was unclear whether the “voices” they reported hearing 
were perceived as being produced by external entities or as strong internally-based 
negative cognitions.  Although controversial, Verdoux and van Os (2002) proposed that 
psychotic symptoms are best conceptualized as following a continuum of severity rather 
than as a categorical distinction between normal and abnormal thought processes.  
Furthermore, the philosophy underlying ACT theorizes that similar processes may 
account for both milder forms of dysfunctional thinking (e.g., negative automatic 
thoughts) and active, externally-experienced perceptual abnormalities (e.g., auditory 
hallucinations).  Both ACT and more traditional CBT attempt to normalize psychotic 
experiences to decrease patient distress.  Therefore, the presence of “hallucinations” was 
more broadly defined in the study to include this broader continuum of abnormal thought 
process.   
2.2. Measures 
 2.2.1. Brief Psychiatric Rating Scale (BPRS).  The BPRS, one of the most widely-
used psychiatric rating scales, is an 18-item semi-structured clinical interview used to 
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assess general psychopathology, positive and negative symptoms, as well as 
disorganization and mood problems (Lukoff, et al., 1986; Overall & Gorham, 1962).  The 
BPRS has been shown to consist of four independent factors, and Thinking Disturbance 
(positive symptoms), Anergia (negative symptoms), Affect (depression, anxiety, 
hostility), and Disorganization subscales can be computed (Long & Brekke, 1999; 
Mueser, Curran, & McHugo, 1997).   Furthermore, the BPRS is a valid measure that is 
sensitive to change in acute inpatient care settings (Varner, Chen, Swann, & Moeller, 
2000).  Anchor points and descriptors were used in the current study as Gabbard et al. 
(1987) found that they increased interrater reliability.  Furthermore, raters were trained to 
proficiency based on the manual by Ventura et al. (1993). 
 2.2.2 Clinical Global Impression Scales (CGI).  The CGI (National Institutes of 
Mental Health, 1985) is a global rating of severity and improvement based on a 7-point 
Likert scale:  1 = “Normal, not at all ill” to 7 = “Among the most extremely ill patients.”  
The CGI has high interrater reliability and has been used extensively in psychiatric 
outcome research. Anchor points and descriptors were used to increase reliability of 
administration.  For example, “moderately ill” (4) is defined as “meets full criteria for 
psychiatric diagnosis.”  Improvement ratings were made based on comparisons to pre-
treatment assessment ratings. 
 2.2.3. Self-Ratings of Psychotic Symptoms.  Psychotic symptoms also were 
assessed in a manner similar to those developed by Bach and Hayes (2002).  Participants 
were asked to rate the frequency, believability, and distress associated with their 
hallucinations and/or delusions on a Likert-scale format (see Appendix A).  For example, 
for frequency of hallucinations, participants were asked, “On average, how often have 
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you heard voices in the past month?”  1 = Never; 2 = less than once a week; 3 = about 
once a week; 4 = several times a week; 5 = daily; 6 = more than once a day; 7 = almost 
constant. 
 2.2.4. Sheehan Disability Scale (SDS).  The SDS is a self-report measure of 
impairment due to a psychiatric illness (Leon, Olfson, Portera, Farber, & Sheehan, 1992).  
Participants rated their impairment from symptoms in family, work, and social domains 
based on a 10-point Likert scale format.  The SDS has high internal consistency and good 
construct validity.  It also has evidence of criterion-related validity for impairment 
associated with psychiatric disorders (Leon, Shear, Portera, & Klerman, 1992).    
 2.2.5. Rehospitalization data.  Rehospitalization data were collected by contacting 
the patient’s insurance provider at 4-month follow up.  It was estimated that 80 to 90 
percent of participants would be insured through the same provider, Community 
Behavioral Health (CBH), which dispenses Medicaid funds for the city of Philadelphia.  
CBH possesses records of any participant psychiatric hospitalizations in the Philadelphia 
area since discharge.  Data also were obtained from those who were rehospitalized on the 
Hahnemann unit during the follow-up period.   
2.3. Treatments 
 2.3.1. Enhanced treatment as usual (ETAU).  ETAU consisted of 
psychopharmacology and individual and group psychotherapy on the unit.  All patients 
participating in the study were taking anti-psychotic and/or other psychotropic 
medication during their inpatient stay.  Once patients were stabilized on their 
medications, they participated in standard milieu therapy on the unit.  Supportive and 
psychoeducational group treatment was conducted by psychologists, social workers, 
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mental health technicians, and psychology interns.  Patients also received some 
individual therapy and case management as appropriate.  Patients were referred to 
appropriate community services upon discharge. 
Furthermore, patients’ participation in the study required them to undergo a 
comprehensive assessment of psychiatric symptoms.  These results were discussed with 
the treatment team and used for treatment planning purposes.  In order to help control for 
the confound of extra individual attention in the ETAU+ACT condition, the ACT 
therapist met with participants in the ETAU condition almost daily to provide additional 
support and to answer questions.  The goal was to establish a rapport with the ETAU only 
participants and to identify useful clinical information that may be relevant for treatment 
planning.  Care was made not to discuss or suggest coping strategies related to ACT.  
However, extra therapist contact was provided as needed and not based on a specific 
protocol, and so the amount of extra contact time varied by participant.  ETAU 
participants were receiving equal amounts of actual therapy contact time compared to 
ACT participants, as treatment in the groups was done concurrently.  In general, this 
extra contact with the ACT therapist for participants in the ETAU condition was 
necessarily less than that provided to participants specifically receiving ACT sessions.   
 2.3.2. Acceptance and Commitment Therapy (ACT).  The ACT protocol used in 
the current study was delivered in an individual format and was based on a modified 
treatment manual developed by Hayes et al. (1999) and Bach & Hayes (2002).  Patients 
received approximately 3 ACT sessions in lieu of other group/individual sessions as part 
of ETAU on the unit and according to their length of stay.  The ACT protocol was 
developed so that patients could participant in treatment as their stay dictated.  
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Specifically, each 1-hour session contained a core set of components that allowed 
participants to participate in the number of individual sessions appropriate to their length 
of stay.  Each session began with an educational component that addressed psychotic 
symptoms.  Next, goals and valued behaviors were elicited and the role of disturbing 
thoughts/emotions as barriers to goal attainment was discussed.  The ACT model then 
was presented to provide a rationale for treatment.  Various mindfulness and acceptance 
exercises were practiced to decrease avoidance or struggle with internal experiences.  
Instead, patients were taught to accept and experience symptoms nonjudgmentally 
without allowing them to interfere with goal-directed behavior.  In this way, patients 
decreased their tendency to interpret psychotic symptoms as representing reality, similar 
to in other CBT approaches.  Each session ended with a review and suggestions for 
practice exercises to attempt between sessions.  A core set of mindfulness/acceptance 
exercises were rotated through sessions.  See Appendix B for the detailed treatment 
manual. 
2.4. Procedure 
 Patients in the inpatient unit at Hahnemann University Hospital underwent routine 
assessment procedures, which included a psychiatric evaluation to determine DSM 
diagnosis.  Potential candidates who meet criteria for the study were referred by the 
supervising psychologist through the routine review of patient records.  Patients were 
approached by the author to determine their interest in the study once stabilized on 
medication enough to participate in group therapy on the unit and after consultation with 
their treatment team.  If patients agreed to participate, informed consent was obtained and 
demographic information collected.   
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Immediately after obtaining consent, participants completed assessment measures 
and afterward were randomly assigned to ETAU or ETAU+ACT.  One therapist 
conducted all ACT sessions.  Clinician ratings were conducted by the therapist or one of 
two research assistants for both groups.  Raters were not blind to treatment allocation.  
Patients in the ETAU condition received standard treatment on the unit, which included 
psychoeducational-supportive therapy and pharmacotherapy.  Patients in the 
ETAU+ACT condition received 1 to 5 sessions of individual ACT according to their 
length of stay.  The treatment team was consulted throughout patients’ participation in the 
study.  If a patient appeared to develop an adverse reaction to treatment, the plan was to 
withdraw the individual from the study and provide standard care; also, the treatment 
team would be notified immediately.  No such actions were necessary during the study.  
Prior to discharge, participants completed the same assessment measures.  All patients 
were discharged to appropriate community services, which included case management 
and community outpatient care.  At 4-month follow-up, rehospitalization data were 
obtained from patients’ insurance providers by phone.  See Table 3 for a summary of 
assessment procedures. 
2.5. Reliability/Fidelity Checks 
 Although initially proposed that ACT sessions would be videotaped or audiotaped 
to assess treatment fidelity, most patients would not agree to this practice.  However, 
regular supervision and consultation was provided by Dr. James Herbert, an expert in 
ACT who closely oversaw the project, and Dr. David Kalal, the supervising psychologist 
on the unit, to ensure protocol fidelity.  Furthermore, a random proportion (approximately 
5%) of assessments were conducted by one assessor while another assessor observed and 
 
28 
recorded independent ratings, which were then compared for reliability.  Interrater 
agreement for clinician ratings (i.e., BPRS, CGI) was high (interclass correlation = .90), 
suggesting reliable administration of measures.  Self-report measures were administered 
at the same assessment as the clinician ratings.  The assessor read self-report questions to 
patients who were illiterate, and recorded patients’ exact response without further query.   
2.6. Statistical Analyses 
 2.6.1. Statistical power.  The a priori sample size was determined by examining 
the hypothesis that ACT would result in superior outcomes compared to ETAU.  Both 
recent meta-analyses conducted comparing CBT for psychosis and a comparison control 
condition showed large effect size differences (Gould et al., 2001; Rector & Beck, 2001).  
Using the computer program G-Power (Faul & Erdfelder, 1992), power was calculated 
for analysis of variance with an alpha set at .05 and a large effect size (f = .45).  A sample 
size of 21 participants per group (total n = 42) was estimated to yield a power of .80, 
which Cohen (1988) designated as acceptable for behavioral research.   
   2.6.2. Preliminary analyses.  An alpha level of .05 and two-tailed tests were used 
in the analyses unless otherwise specified.  Marginally significant results (p < .10) were 
noted accordingly due to modest sample size.  Random assignment to conditions was 
expected to result in relatively equal groups.  However, a series of independent samples t-
tests and chi square tests was conducted to determine if participants in the groups differed 
in symptom severity on pretest measures or on demographic characteristics.  If significant 
differences were found, covariance analyses were employed in subsequent analyses.  In 
addition, those in the ETAU+ACT condition received a variable number of individual 
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sessions.  Therefore, a Pearsons correlation were calculated to determine if the number of 
sessions was associated with outcome.   
 2.6.3. Primary analyses.  Primary analyses were conducted on treatment 
completers.  To test the hypothesis that those receiving ACT would demonstrate 
improved outcomes compared to those receiving ETAU only, continuous measures were 
analyzed by means of analysis of variance (ANOVA), with pre-treatment scores used as 
covariates where appropriate (as recommended by Behar and Borkovec, 2003).  Due to 
small sample size, multivariate tests were not used, as they would likely increase Type II 
error. 
Rehospitalization data were calculated in the following ways:  1) whether or not 
participants were rehospitalized during the 4-month follow-up period was used as a 
categorical measure; and 2) the number of days until rehospitalization was used as a 
continuous measure.  Categorical data were analyzed based on a chi square test.  Days 
until rehospitalization was analyzed by computing a Kaplan-Meier survival analysis.   
2.6.4. Secondary analyses.  Intention-to-treat analyses also were conducted on 
outcome measures using the last observation carried forward method to examine the 
entire sample.  In addition, analyses were conducted to examine the proportion of patients 
within each condition who achieved substantial amelioration of symptoms or a clinically 
significant change (Jacobson & Truax, 1991).  Treatment responders were defined as 
those demonstrating a pre- to post-treatment gain of at least 2 pre-treatment standard 
deviation units on the BPRS total score or thinking disturbance subscale.  Chi square 
analyses were conducted to examine differential rates of responders in the two 
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conditions.  Also, effect sizes based on Cohen’s d statistic1 were computed for the BPRS 
total score and thinking disturbance subscale. 
Finally, regression analyses were conducted to determine if believability in 
symptoms mediated the relationship between frequency of hallucinations and associated 
distress.  Mediation analyses were conducted based on the recommendations by Baron 
and Kenny (1986).  Furthermore, it was hypothesized that believability in psychotic 
symptoms would be a predictor of distress, especially for those in the ACT condition.  
Separate regression analyses were conducted by group to determine if pre-post changes in 
believability predicted change in distress beyond change in frequency alone.   
2.7. Design and Data Collection Considerations 
 An effort was made in the current study to construct the simplest and most 
straightforward design that could adequately examine the hypotheses.  However, several 
possible experimental difficulties were identified and alternative approaches considered.  
On an inpatient unit, patients often are discharged with little notice, and therefore it was 
difficult to obtain complete post-treatment data on all participants.  If a patient was 
unable to complete the full assessment procedures prior to discharge, assessors attempted 
to obtain as much outcome data from the person as possible.  In addition, it was difficult 
to obtain follow-up data on all patients as many were homeless and did not have 
permanent contact information.  Therefore, different methods of obtaining 
rehospitalization data were considered.  For example, although it is preferable to obtain 
rehospitalization data through patient records, attempts were made to contact participants 
if this information could not be obtained from insurance providers.  Furthermore, upon 
                                                 
                                                                                                                        _______________ 
1Cohen’s (1988) d statistic:  (M1-M2)/(SD pooled), where SD pooled = [√(SDpre2 + SDpost2)/2]. 
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consent, patients were asked to provide alternative persons who can be contacted if there 
was a problem contacting the patient at follow-up.    
 Many individuals with serious mental illness are already receiving a variety of 
treatments, including medication and case management.  Therefore, alternative strategies 
for identifying and implementing evidence-based treatments for serious mental illness 
compared to other common psychiatric conditions (e.g., mood or anxiety disorders) are 
warranted (Mueser, Torrey, Lynde, Singer, & Drake, 2003).  Bach and Hayes (2002) 
compared TAU versus TAU plus additional treatment.  The current study employed a 
design comparing ACT versus other psychoeducational-supportive treatment provided as 
part of TAU.  ACT sessions were given in place of another group or individual session 
provided as TAU on the unit.  This design helped to limit the potential confound of 
additional treatment.  However, it should be noted that the primary delivery format for 
TAU consisted mainly of group sessions.  It originally was proposed that ACT be 
delivered in a group format; however, due to high turnover rate and limited resources, 
such a format was not feasible in the study so ACT was delivered in individual sessions. 
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3. RESULTS 
3.1. Sample Description 
 Figure 1 depicts a diagram showing participant flow throughout study phases.  A 
total of 60 participants were approached for inclusion in the study based on pre-screening 
procedures.  Fifteen patients refused entry into the study after it was described.  Three 
participants did not meet inclusion/exclusion criteria for the study:  two were floridly 
psychotic and one did not meet diagnostic criteria upon further assessment.  Therefore, 
42 participants met study criteria, provided informed consent, completed pre-treatment 
assessments, and were randomized to treatment (ETAU n = 21; ACT n = 21).  Of this 
group, two participants did not start treatment in the ACT condition due to unexpected 
discharge from the unit.  Furthermore, one participant later withdrew from the ACT 
condition and one from the ETAU condition. 
 Average length of stay on the unit was 10.7 days (SD = 11.5).  Those in the ACT 
condition received an average of 3 treatment sessions (M, Mode, Med = 3; min = 1, max 
= 5).  Average age of participants was 40 (SD = 10).   The sample was 64% male and 
race was predominately African-American (88%).  Educational attainment was relatively 
low in the sample, with 35% not graduating high school, 36% obtaining a high school 
diploma or GED, and 17% having some post-secondary education.  The majority of 
participants were unemployed or receiving disability compensation (86%), with only 
13% working full- or part-time.   Only 12% of participants had private insurance.  
Regarding housing status, 29% were homeless or living in a shelter, 38% were living 
with family or friends, 12% were renting/owning property, and 17% were living in 
supervised housing (e.g., nursing home).  Only 12% of participants were married, with 
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the remaining single, divorced, or widowed.  The majority of participants carried a 
primary diagnosis of a psychotic disorder (60%), with the remaining diagnosed with a 
major mood disorder with psychotic symptoms.  Over half of the participants possessed a 
comorbid substance use disorder and 82% had at least one major medical condition.  See 
Table 3 for a detailed breakdown of demographic characteristics. 
3.2. Preliminary Analyses 
 3.2.1. Demographic characteristics.  Analyses were conducted using an alpha 
level of .05 and two-tailed tests unless otherwise specified.  Due to small sample size, 
marginally significant results (p < .10) also were noted.  Preliminary analyses were 
conducted to examine the comparability of groups on pretest measures.  Independent-
samples t-tests were conducted between the groups on participant age and length of stay 
on the unit.  No significant differences were found (ps = n.s.).  Chi square tests were not 
significant between groups for race, level of education, relationship status, employment 
status, housing status, insurance coverage, primary diagnosis, presence of a substance use 
disorder, or presence of a major medical condition (all ps = n.s.).  However, there was a 
significant difference found between groups for gender (χ1= 8.40, p < .01).  There were 
significantly more female participants in the ACT condition (57%) compared to the 
ETAU condition (14%).   
3.2.2. Pre-treatment scores.  Pretest scores between groups were evaluated using 
independent-samples t-tests.  Results showed no significant differences for self-reported 
hallucination frequency, distress, or believability; or for BPRS total scores or anergia, 
affect, and disorganization subscales (all ps = n.s.).  A significant difference was found 
for the BPRS thinking disturbance subscale (t40 = 3.86, p < .01).  Marginally significant 
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differences were found for the BPRS affect (t40 = 2.43, p = .067) and disorganization (t40 
= 1.62, p = .053) subscales.  Specifically, the ACT group showed greater severity on the 
BPRS affect subscale, whereas the ETAU group showed greater severity on the thinking 
disturbance and disorganization subscales.  Based on recommendations by Behar and 
Borkovec (2003) and due to the identified pretest differences between groups, pretest 
scores were used as covariates in the primary analyses. 
3.2.3. Gender differences.  Due to gender differences between groups, follow-up 
chi square and t-tests were computed by gender on demographic characteristics and 
pretest scores.  Significant differences were found between gender and relationship status 
(χ1= 13.59, p < .01) and comorbid substance use disorder (χ1= 5.41, p < .05).  
Specifically, males were more likely than females to be single (80% vs. 27%, 
respectively) and to possess a comorbid substance use disorder (70% vs. 33%, 
respectively).  In addition, a significant difference was found between males and females 
on the BPRS affect subscale (t40 = 3.90, p < .001). Also, a marginally significant 
difference was found for gender and the BPRS thinking disturbance subscale (t40 = 1.80, 
p = .079).  Specifically, males showed greater severity on the BPRS thinking disturbance 
subscale (male M =13.6; female M = 10.9), whereas females showed greater severity on 
the BPRS affect subscale (male M =21.4; female M = 26.1).  No other significant 
differences were found (all ps = n.s.).  Due to low gender x treatment cell sizes, statistical 
examination of post-treatment measures was not possible.  However, visual examination 
of post-treatment means did not suggest any systematic differences within groups by 
gender. 
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In summary, males showed greater severity of psychotic symptoms and more 
comorbid substance use than females, who possessed more severe mood and anxiety 
problems.  However, gender was not used in the following analyses as a covariate.  It was 
deemed more appropriate to control for any pre-treatment differences than gender per se, 
as such a procedure would be technically possible but conceptually problematic.    
3.2.4. Other analyses.  The demographic characteristics of those who agreed to 
participate in the study were compared to those who refused using chi square or 
independent-samples t-tests where appropriate.  No significant differences were found 
(all ps = n.s.).  Finally, a Pearsons correlation calculated between BPRS total score and 
number of ACT sessions provided was not significant (p = n.s.), suggesting that number 
of sessions provided was not associated with outcome.    
3.3. Primary Analyses2 
 Of the thirty-eight participants who completed treatment, post-treatment data were 
missing for 9 participants due to their departure from the unit prior to completing the 
assessments.  Therefore, completer analyses were conducted on the remaining 15 
participants in the ETAU condition and 14 participants in the ACT condition.  See Table 
4 for a depiction of raw score means and standard deviations for outcome measures 
(before evaluation at covariates).     
3.3.1. Clinician-rated measures.  Separate analyses of covariance (ANCOVAs) 
were conducted on BPRS scales, using pretest scores as covariates.  A marginally 
                                                 
2 Due to multiple individual group comparisons that could increase Type I error, data also were interpreted 
based on a Bonferroni corrected alpha level of .004 (Bonferroni-corrected α = .05/n, where n = 12 group 
comparisons).  Based on the Bonferroni correction, no significant differences would be identified.  
However, due to the modest sample size for group comparisons in the study, this correction would likely be 
overly conservative and inflate Type II error.  Thus, considering the relatively small sample size, the 
preliminary nature of this study, and the importance of balancing Type I and Type II error, unadjusted p 
values are reported.   
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significant difference was found on the BPRS affect subscale (F1, 26 = 3.47, p = .074), 
with those in the ACT condition (M = 15.6)3 showing greater improvement compared to 
the ETAU condition (M = 18.9).  See Figure 2.  No significant differences were found 
between the groups on the BPRS total or thinking disturbance, anergia, and 
disorganization subscales (all ps = n.s.).   
 An ANCOVA was conducted on CGI severity ratings, using pretest scores as the 
covariate.  No significant difference was found (p = n.s.).  In addition, an independent-
samples t-test was conducted to examine CGI improvement ratings at post-treatment.  A 
marginally significant difference was found (t27 = 2.00, p = .053), with the ACT group (M 
= 2.3) showing greater improvement at post compared to the ETAU group (M = 3.0).     
3.3.2. Self-report measures.  Separate ANCOVAs were conducted for frequency, 
distress, and believability of hallucinations at post-treatment, using pre-treatment scores 
as covariates.4  A significant difference between groups was found in distress from 
hallucinations (F1, 26 = 4.62, p < .05), with the ACT group (M = 5.7) showing greater 
improvement compared to the ETAU group (M = 7.6).  See Figure 3.  No significant 
differences were found for frequency or believability associated with hallucinations (ps = 
n.s.). 
 Separate ANCOVAs were conducted on the SDS work, social, and family 
subscales.  A significant difference was found between the groups on the SDS social 
subscale (F1, 26 = 9.09, p < .01), with the ACT group (M = 5.9) showing greater 
improvement compared to the ETAU group (M = 8.2).  See Figure 4.  No significant 
differences were found for the SDS work or family subscales (ps = n.s).   
                                                 
3 Note that the means presented in text are based on covariate analyses. 
4 Too few participants self-reported delusions for analyses to be conducted (total n = 8). 
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 3.3.3. Objective measures.  At 4-month follow-up, 45% of participants in the 
ETAU only condition (9/20) were rehospitalized compared to only 28% of those in the 
ACT condition (5/18).  However, the chi square test was not significant (p = n.s.).  A 
Kaplan-Meier survival analysis was conducted on time to rehospitalization between 
groups over the follow-up period.  No significant difference was found (p = n.s.).   
3.4. Secondary Analyses   
3.4.1. Intention-to-treat analyses (ITT).  Because of problems with missing data at 
post-treatment, the last observation carried forward method was used for ITT analyses 
(ETAU n = 21; ACT n = 21).  As with completers only, separate ANCOVAs with pretest 
scores as covariates were used to examine ITT data.  Similar to results in completers 
only, significant differences were found at post-treatment between groups on the SDS 
social subscale (F1, 38 = 4.70, p < .05) and self-reported distress associated with 
hallucinations (F1, 39 = 6.30, p < .05) favoring the ACT group.  No other significant 
differences were found (all ps = n.s.). 
3.4.2. Clinically significant change.  Responders were defined as participants who 
showed at least 2 standard deviations improvement (Jacobson & Truax, 1996) on the 
BPRS total score and thinking disturbance subscale.  Based on chi square results, a 
significant difference was found in improvement on BPRS total scores between groups 
(χ1 = 6.81, p < .01).  Significantly more participants reached a clinically significant 
improvement in the ACT group (50%) compared to the ETAU group (7%).  No 
significant difference was found between the groups in clinically significant improvement 
on the BPRS thinking disturbance subscale (p = n.s.).  See Figure 5.   
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 In addition, effect sizes (Cohen’s d) were calculated for changes on the BPRS 
total score and thinking disturbance subscale.  According to Cohen’s (1988) guidelines, 
the ACT and ETAU groups showed large effect size gains from pre- to post-treatment.  
Furthermore, the ACT group showed medium effect size gains compared to the ETAU 
only group at post-treatment.  See Table 5.   
 3.4.3. Regression analyses.  An analysis was conducted to examine whether 
believability in hallucinations mediated the relationship between frequency of 
hallucinations and associated distress.  Based on the recommendations by Baron and 
Kenny (1986), three independent regression equations were computed:  regressing the 
mediator (i.e., believability) on the independent variable (i.e., frequency); regressing the 
dependent variable (i.e., distress) on the independent variable; and regressing the 
dependent variable on both the independent and mediator variables.  Mediation occurs if 
the first two regressions are significant, and in the third equation, the strength of the 
relationship between the independent and dependent variables is decreased by inclusion 
of the mediator.  The following self-report measures were used in the analyses:  
hallucination frequency over the past month (retrospectively assessed at pre-treatment), 
current distress associated with these hallucinations (assessed at pre-treatment), and post-
treatment distress associated with these hallucinations. 
 All the above conditions were met.  Frequency of hallucinations over the past 
month significantly predicted pre-treatment believability of hallucinations (β = .69, t41 = 
5.96, p < .001).  Frequency also predicted post-treatment distress about hallucinations (β 
= .44, t41= 2.55, p < .05).  Finally, believability (β = .52, t41 = 2.56, p < .05) but not 
frequency of hallucinations (p = .61) predicted associated distress.  Testing the standard 
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error of the indirect effect using the Sobel test indicated that believability mediated the 
relationship between frequency of hallucinations and associated distress (t41 = 2.35, p = 
.05).  These results are consistent with the hypothesis that the increased frequency of 
hallucinations would lead to stronger believability in them, which in turn would result in 
more distress.  However, results are tempered by the possible confound of the 
retrospective reporting of hallucination frequency.   
 The relationship between believability in hallucinations, associated distress, and 
treatment outcome also was explored.  First, repeated-measures ANOVAs were 
conducted to examine pre- to post-treatment changes in distress separately for each 
group.  A significant time main effect showing decreases in distress related to 
hallucinations was found for the ACT group (F1, 13 = 5.56, p < .05) but not the ETAU 
group (p = n.s.).  Next, a multiple regression analysis was conducted to test whether 
change in believability of hallucinations predicted associated distress beyond change in 
their frequency for the ACT group.  Change in frequency was entered into the regression 
equation first followed by change in believability to predict change in distress.  Change in 
believability was an independent predictor of change in distress beyond change in 
frequency, which was only marginally significant (p = .062).  The same regression 
analysis was not significant when run on the ETAU only group (p = n.s.) as expected 
because no significant time effect on believability of psychotic symptoms was found.  
See Table 6. 
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4. DISCUSSION 
4.1. Summary of Results 
 The current study was a randomized trial to investigate if ACT was superior to 
ETAU in treating psychiatric inpatients with psychotic symptoms.  Results suggested 
superiority of ACT on clinician-rated affective symptoms and global improvement, and 
self-reported distress associated with hallucinations and disability associated with social 
functioning at post-treatment.  Furthermore, significantly more participants in the ACT 
group achieved clinically significant improvement in general psychopathology.  Overall, 
both groups showed large effect size improvements at post-treatment, with the ACT 
group showing medium effect size gains compared to the ETAU group.  Results 
supported the hypothesis that believability in hallucinations is a mediator of the 
relationship between symptom frequency and associated distress.  Furthermore, pre- to 
post-treatment decreases in believability were observed only in the ACT group, and 
change in believability predicted change in associated distress after controlling for 
change in symptom frequency.  At 4-month follow-up, 28% of the ACT group compared 
to 45% of the ETAU group were rehospitalized. 
4.2. Support for Hypotheses 
 4.2.1. Hypothesis #1.  It was hypothesized that those receiving ACT would show 
superior gains compared to those receiving ETAU at post-treatment.  In general, this 
hypothesis was supported, but only in limited domains.  As mentioned, the ACT group 
showed superiority to ETAU on measures related to affective severity, global 
improvement, distress associated with hallucinations, and disability related to social 
functioning.  Furthermore, the ACT group showed more clinically significant 
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improvement compared to the ETAU group.  Nevertheless, no significant differences 
between groups were observed on a number other measures, most notably those related to 
the frequency or severity of psychotic symptoms.   
Furthermore, effect size differences between groups were in the medium range.  
Although raw improvement on almost all measures favored the ACT group (see Table 4), 
the study appears to have been underpowered to detect these more modest between-group 
differences.  Other studies of CBT for psychosis generally have reported large effect size 
differences compared to TAU (Gould et al., 2001; Rector & Beck, 2001).  However, 
inability to replicate these findings is not surprising considering differences between the 
current study and past research.   
First, results from previous CBT trials were based largely on studies providing 
intensive outpatient treatment to higher functioning groups, compared to the minimal 
treatment provided to inpatients in an acute episode of illness in the current study.  Drury 
et al. (1996) conducted one of the only randomized trials of CBT for inpatients.  
However, even in this study treatment was quite intensive, consisting of 12 weeks of 
individual and group therapy (approximately 8 hours per week.)  Participants in the 
current study received an average of three 1-hour individual sessions, with some 
receiving as little as one treatment session due to short lengths of stay on the unit.   
Second, fewer group differences are observed when the quality of the comparison 
treatments used in trials is increased (see Lewis et al., 2002; Sensky et al., 2000; Tarrier 
et al., 1998).  In the current study, treatment as usual was enhanced though additional 
therapist contact that patients received for participating in the study.  The thorough pre-
treatment assessments helped the patient’s treatment team provide improved quality of 
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care during hospital stay.  In addition, participants in the ETAU condition met briefly 
with the therapist almost daily, who provided support and answered questions that arose.  
In contrast to the Bach and Hayes (2002) study, groups were matched on therapist contact 
(but not treatment type), as ACT patients received individual sessions during the same 
time that those in the ETAU condition typically received milieu group therapy.  Recently, 
Rector, Seeman, and Zegal (2003) randomly allocated 42 patients with chronic 
schizophrenia to an enhanced treatment as usual condition or to ETAU plus CBT.  A 
statistical advantage in the CBT group was only demonstrated in improvement in 
negative symptoms at 6-month follow-up.  The authors concluded that low power and the 
enhanced nature of the TAU condition resulted in less dramatic group differences.   
Interestingly, the improvements in the ACT group on certain measures in contrast 
to others are consistent with the domains specifically targeted by this treatment.  Whereas 
traditional CBT focuses on symptom reduction, ACT emphasizes decreasing the 
distress/impairment associated with symptoms by enhancing g acceptance.  In the current 
study, ACT and ETAU showed comparable decreases in self-reported frequency of 
hallucinations.  However, only the ACT group showed improvements over time in 
believability of hallucinations.  Furthermore, a significant difference favoring the ACT 
group was found in distress from hallucinations at post-treatment.  It also is noteworthy 
that the ACT group showed improved outcomes compared to ETAU in mood/anxiety 
symptoms and impairment from illness.  Consistent with the aims of the treatment, 
strategies for decreasing distress about hallucinations should have positively impacted 
secondary mood symptoms, and goals/values clarification should have challenged 
perceived impairment from illness.  
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Finally, the differences between groups in clinically significant improvement 
deserve further consideration.  Half of the ACT group (n = 7) showed improvements in 
overall psychopathology (BPRS total score) compared to only 7% (n = 1) of the ETAU 
group.  A further examination of the BPRS thinking disturbance subscale did not suggest 
that differences in overall psychopathology were accounted for by improvements in this 
subgroup of symptoms.  Interestingly, the mean difference between groups on the BPRS 
total score was not significantly different.  This suggests that a subgroup of participants 
did significantly better than others within the ACT group.  Post hoc examination of 
background characteristics between those who did and did not meet criteria for clinically 
significant change did not reveal any obvious differences.  Furthermore, this difference 
was not accounted for by a gender effect.   
4.2.2. Hypothesis #2.  It also was hypothesized that ACT would have positive 
effects on rehospitalization rates.  Only 28% of the ACT group in contrast to 45% of the 
ETAU only group were rehospitalized after 4 months.  Bach and Hayes (2002) found that 
ACT resulted in a 50% reduction in rehospitalization compared to TAU.  Results from 
the current study suggest a 38% reduction in rehospitalization rate in the ACT group 
compared to the ETAU group.  Difference in rehospitalization rate between groups was 
not statistically significant, likely due to low power.  Furthermore, time to relapse (i.e., 
rehospitalization) between groups was not significantly different, although again the 
trend favored the ACT group.  As mentioned, the enhanced nature of the comparison 
treatment and the reduced dose of ACT may have diminished these effects in the current 
study.   
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Although some studies have reported that CBT can be effective in reducing 
rehospitalization rate (e.g., Bach & Hayes, 2002; Norman et al., 2002), others have found 
encouraging trends but not significant effects (e.g., Kuipers et al., 1998; Tarrier et al., 
1999; Tarrier et al., 2004).  Each psychotic episode is associated with an increase in 
residual positive symptoms (Wiersma, Nienhuis, Slooff, & Giel, 1998), and the 
experience of positive symptoms is one of the best predictors of rehospitalization (Tarrier 
et al., 1991).  Therefore, adjunctive psychosocial treatments that have the potential to 
decrease rehospitalization require further study and attention. 
4.2.3. Hypothesis #3.  Believability in hallucinations was thought to be a mediator 
of the relationship between symptom frequency and associated distress.  Therefore, 
change in believability was hypothesized to be predictive of change in distress, 
specifically for the ACT group.  Mediation analyses conducted on pre-treatment scores 
for the entire sample suggested that the degree to which participants believed in their 
hallucinations accounted for the relationship between symptom frequency and distress.  
However, in mediation analyses, it is important to establish the temporal relationship 
between variables.  Because hallucination frequency (retrospective) and believability 
(current) were assessed at pre-treatment, results should be considered tentative and will 
require future prospective designs to confirm.  Furthermore, results showed that 
believability only decreased in the ACT group, and change in this domain was predictive 
of change in distress after controlling for change in symptom frequency.   
ACT is based on Relational Frame Theory (RFT), which is a behaviorally-
oriented theory and research program concerning the nature of language and cognition 
(Hayes, Barnes-Holmes, & Roche, 2001).  The primary assertion of RFT is that verbally-
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mediated private events (e.g., cognitions, emotions, memories, body sensations) do not 
influence behavior directly through their content or frequency, but instead through the 
context in which they occur.  ACT treatment provides individuals an alternate context 
from which to experience private events.  In other words, whereas traditional cognitive 
therapy focuses on directly modifying dysfunctional thought content through rational 
deliberation, ACT focuses on modifying the person’s relationship to his or her thinking 
though the cultivation of metacognitive awareness and acceptance (i.e., separating self 
from thinking).  The results of the current study support this possible mechanism of 
action in ACT. 
Early trials comparing CBT and ACT have tended to yield similar positive 
outcomes, but the two treatments often differ on process measures.  For example, Bruce 
and Bond (2000) examined mediators of change between ACT and a problem-focused 
intervention in reducing worker stress.  Both treatments were associated with 
improvements in mental health and other work-related variables.  However, improvement 
in the ACT condition was mediated only by acceptance of private events, whereas gains 
in the problem-focused condition were mediated by active attempts to modify stressors.  
ACT studies on depression (Zettle & Raines, 1989), math anxiety (Zettle, 2003), social 
anxiety (Block, 2002), and pain tolerance (Hayes et al., 1999) have suggested similar 
processes through which the treatment produces its effects. 
4.3. Comparison and Contrast to Bach and Hayes (2002) 
The current study represents a partial replication and extension of an earlier study 
conducted by Bach and Hayes (2002).  Both studies are comparable in following ways:  
treatment of inpatients with psychotic symptoms, brief individual treatment format, 
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comparison of ACT versus TAU, assessment of self-reported psychotic symptoms, and 
examination of rehospitalization data at 4-month follow-up.  However, the current study 
also possesses unique methodological features.  Although the majority of ACT treatment 
was provided by Bach and Hayes during hospitalization, the final session sometimes 
occurred within a few days after discharge.  All treatment was delivered prior to 
discharge in the current study.  In addition, Bach and Hayes used a 4-session treatment 
protocol.  The amount of treatment in the current study varied based on length of stay.  
Some participants received as few as one or as many as five sessions, although the 
majority received three.  Overall, the dose of treatment was less in the current study 
compared to Bach and Hayes.  Because number of sessions varied in the current study, 
the protocol had to be modified so that each session represented a “stand-alone” ACT 
treatment, including all of the most theoretically relevant components of the treatment.  
In contrast, ACT in the Bach and Hayes study was based on a more traditional, sequential 
model of treatment delivery.   
The decision to deviate from Bach and Hayes (2002) in the aforementioned areas 
was based on two factors.  First, the aim of the current study was to better investigate the 
real-world applicability and external validity of the treatment.  Treatment was delivered 
only during hospitalization because it would be unlikely that inpatient treatment could be 
continued into outpatient in most settings.  Also, due to the variable and short lengths of 
stay in inpatient units today (i.e., approximately one week), few patients would be likely 
to receive a prescribed number of sessions, especially four.  The second reason that the 
current study deviated from Bach and Hayes concerned the unique characteristics of the 
study’s sample.  The sample primarily was comprised of individuals of lower 
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socioeconomic status, many of whom were homeless, making them extremely difficult to 
follow as outpatients.   
The current study differed from Bach and Hayes (2002) in further ways.  
Although the study differences described above mainly concern issues of external 
validity, other changes were made to address internal validity concerns.  In the Bach and 
Hayes study, extra-therapist contact cannot be ruled out as an explanation for treatment 
differences.  To reduce this confound, participants in the ACT condition did not receive 
extra treatment, as ACT sessions were held in the place of other milieu therapy on the 
unit.  Furthermore, modifications were made to enhance TAU in order to balance 
therapist contact between treatments.  For example, feedback from assessments of all 
participants in the study was provided to the treatment team.  Furthermore, the ACT 
therapist met almost daily with participants in the ETAU condition briefly, providing 
non-directive support and answering questions or concerns.  Finally, in the Bach and 
Hayes study, self-reported psychotic symptoms were the only symptom ratings collected.  
In the current study, other standardized clinician-ratings and self-report measures were 
obtained in order to obtain a more multi-modal assessment. 
Although results from the current study were comparable with those of Bach and 
Hayes (2002), differences also were observed, possibly due to these differences in 
methodology.  Bach and Hayes found that the ACT group reported higher psychotic 
symptom frequency compared to the TAU group, comparable decreases in associated 
distress over time across the groups, but lower believability of psychotic symptoms 
compared to the TAU group.  In the current study, hallucination frequency decreased 
comparably in both groups over time, the ACT group showed lower distress related to 
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hallucinations, and believability significantly decreased only in the ACT group over time.  
One explanation for the observed differences may be due to the timing of assessments.  
The current study collected self-ratings of psychotic symptoms at pre- and post-treatment, 
whereas the Bach and Hayes results were based on ratings obtained at pre-treatment and 
4-month follow-up.   
Finally, the present study found a 38% decrease in rehospitalization in the ACT 
group compared to a 50% reduction in the Bach and Hayes study.  This discrepancy 
could have been due to a number of reasons, including differences in treatment dose, 
sample characteristics, and the enhanced nature of the TAU group.  However, this 
discrepancy may simply be within the range of normal variability considering the small 
sample size in the current study.  See Table 7 for a summary. 
4.4. Limitations 
 The present study possessed several strengths, including randomization to 
conditions, use of standardized assessment measures, collection of follow-up  
rehospitalization data, and diversity of sample demographics.  However, potential 
limitations in the study included small sample size, treatment heterogeneity, and non-
blinded assessors, which warrant further consideration when interpreting results.   
First, sample size in the current study was relatively modest, especially due to 
missing data at post-treatment, as abrupt patient discharges were common.  A priori 
power analysis was based on an assumed large effect size difference between groups; 
however, results revealed that actual differences tended to be in the medium range.  This 
resulted in corresponding low statistical power to detect differences between groups.  In 
order to help address this problem, ITT/LOCF analyses were conducted, which revealed 
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similar findings.  Furthermore, results in the current study were largely consistent with 
those found by Bach and Hayes (2002) with twice the current sample size.     
Another potential limitation was treatment heterogeneity.  Number of ACT 
sessions varied from one to five, with the majority receiving three.  As discussed 
previously, the decision to vary treatment length was made to better reflect the way 
treatment typically would be delivered in an inpatient environment, as length of stay 
varies dramatically between patients.  Number of sessions provided in the ACT condition 
varied as a function of participants’ length of stay on the unit.  A patient who was 
discharged after a few days may have received only one session, whereas someone 
hospitalized for a few weeks may have received as many as five sessions.  There was no 
association found between number of sessions and treatment outcome in the study. 
Furthermore, although therapist contact was kept roughly equivalent between 
groups, type of treatment was often different.  Milieu therapy could include both group 
and individual therapy.  However, the majority of individuals in the ETAU condition 
received only group therapy, whereas all ACT sessions were delivered in an individual 
format.  Therefore, differences between groups could have been a factor of the format of 
treatment in contrast to ACT specifically. 
A drawback of the study was that assessors and staff were not blind to treatment 
allocation.  Furthermore, it is possible that demand characteristics could have influenced 
self-report ratings, as they were collected at the same time as the clinical assessment.  
However, the following points are important to consider.  Outcome was assessed in a 
multi-modal fashion and included self-report, clinician ratings, and objective measures.  
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Regardless of assessment method, results consistently favored the ACT group, and even 
when significant differences were not found, the trend was similar.   
Another potential confound was that the therapist sometimes was the assessor at 
post-treatment.  However, in order to reduce this potential bias, the ACT therapist met 
frequently with participants in the ETAU only condition, who considered the ACT 
therapist to be their own therapist.  Furthermore, interrater agreement on clinician 
measures was high (interclass correlation = .90), suggesting reliable administration of 
measures.   
Finally, the composition of the sample is important to consider.  One strength of 
the current study was that the majority of participants were non-Caucasian, in contrast to 
previous studies in which samples were mostly comprised of Caucasian patients.  It was a 
helpful contribution to the literature to examine treatment of psychosis in this more 
racially diverse sample.  Furthermore, the sample in the current study was comprised of a 
relatively severe group of patients, even for inpatient standards.  Many were homeless, 
possessed serious comorbid medical and psychiatric conditions and substance use 
problems, and were of lower educational attainment.  However, the study demonstrated 
that ACT could be adapted successfully to treat these patients with minimal alterations in 
the protocol.  The more unique a sample, the less readily one can generalize the results of 
the study to other populations.  Relatively few participants in the current study had 
prominent delusions, so the findings may be most applicable to individuals experiencing 
hallucinations.  Some evidence suggests that cognitive-behavioral therapies may be 
particularly useful for treating hallucinations (Lewis et al., 2002; Tarrier et al., 2001).  
Similarities in results between the current study and that of Bach and Hayes (2002) 
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suggest that ACT can be modified for different populations with similar success.  
Nevertheless, generalizability to schizophrenic populations specifically may be limited 
due to the mixed diagnostic status of participants in both studies. 
4.5. Implications and Future Directions 
 The present study supported the conclusions of Bach and Hayes (2002) 
concerning the benefit of ACT for the treatment of inpatients with psychotic symptoms.  
In both studies, outcome with ACT was superior to TAU.  Similar results have been 
reported in trials examining more traditional CBT approaches for schizophrenia and 
related psychotic disorders.  However, in trials comparing CBT with supportive therapy, 
the specific benefits of CBT become more modest, or disappear altogether.  Therefore, it 
will be important for future research to compare ACT to other active treatments within 
studies that better control for non-specific factors. 
 Neither Bach and Hayes (2002) nor the current study was designed to support the 
conclusion that ACT is a specifically efficacious treatment for psychotic disorders, as the 
comparison groups used did not control for all non-specific treatment factors, such as 
treatment type, credibility, novelty, etc.  Results of the Bach and Hayes trial suggested 
that additional treatment was beneficial for inpatients.  The current study replicated and 
extended these findings to suggest that individual treatment, even if brief, helps patients 
cope better with psychotic symptoms compared to milieu group therapy.  Based on these 
preliminary but suggestive findings, future studies with larger samples are warranted.  
Furthermore, future trials should begin to examine systematically the relative efficacy of 
CBT, ACT, and other empirically-supported treatments for psychosis (Gaudiano, in 
press).   
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One possibility is that both CBT and ACT will yield comparable results, yet 
operate through different mechanisms of action.  The current study suggests the 
importance of targeting believability in psychotic symptoms in contrast to their frequency 
per se.  Traditional cognitive-behavioral theories tend to focus on the importance of 
decreasing the frequency of symptoms, whereas ACT, based on RFT, suggests that the 
focus should be on undermining believability to impact distress.  Results of the current 
study were consistent with the hypothesis that believability mediates the relationship 
between frequency and associated distress, and that ACT specifically affects believability 
to lessen distress.  However, change in the frequency of hallucinations also predicted 
distress in the current study.  Therefore, and consistent with their relative theories, both 
CBT and ACT are likely to produce improvement, possibility through different 
mechanisms of action.  This examination of potential mediators/moderators of treatment 
outcome will become particularly important in future studies.  In particular, future 
research should assess these variables in a prospective manner to establish the temporal 
relationships that can confirm mediation effects.  Specifically, variables such as psychotic 
symptom frequency, believability, and distress should be assessed at different time 
periods, including at various points during treatment (e.g., baseline, pre-treatment, mid-
treatment, post-treatment, and follow-up). 
Furthermore, alternate explanations for the observed effects deserve further 
consideration.  The current study and the Bach and Hayes (2002) study showed 
demonstrable treatment effects with only minimal ACT treatment.  Similarly, brief 
treatment has been shown to be effective using a more traditional CBT approach.  For 
example, Turkington et al. (2002) randomly assigned 422 patients with schizophrenia 
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living in the community to CBT or TAU.  Psychiatric nurses were trained to deliver 6, 
hour-long sessions of CBT.  Results revealed that those in the CBT condition showed 
greater improvement in overall symptomatology, insight, and depression compared to the 
TAU group; however, there was no difference in psychotic symptom improvement 
between groups.  Others have experimented with the use of briefer group treatments for 
auditory hallucinations with promising effects (Chadwick, Sambrooke, Rasch, & Davies, 
2000; Wykes, Parr, & Landau, 1999).     
Lambert (in press) asserts that early treatment response suggests the role of non-
specific treatment factors, as the effect is produced before the patient would be expected 
to practice and to obtain the positive benefits from the coping skills taught in sessions.  
To further support his hypothesis that non-specific factors account for improvement in 
psychotherapy, Lambert points to other intriguing findings:  the lack of contrast in effects 
based on expertise of therapists, the frequent null findings in comparative outcome and 
dismantling studies, and the observation that a substantial proportion of treatment 
response is produced after only the first few sessions in cognitive therapy.  However, 
alternative explanations for early treatment response also exist.  For example, Fennel and 
Teasdale’s (1997) analysis of CBT for depression suggested that early responders were 
better able to negotiate therapeutic tasks in therapy.  In addition, Renaud et al. (1998) 
found that early response was most dramatic in a nondirective supportive treatment 
compared to CBT in the treatment of adolescents with depression.  Future studies will 
require the use of control conditions that better control for non-specific treatment factors 
to demonstrate specificity of treatments for psychosis.  Furthermore, the examination of 
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process measures during early phases of treatment may help in the separation of specific 
and non-specific effects. 
Finally, the present study demonstrated that ACT can be easily and minimally 
adapted for various patient populations and settings.  Perhaps one of the most useful 
features of the treatment is that it proposes a theoretical explanation for human suffering 
that can be used to conceptualize and treat conditions as diverse as math anxiety and 
schizophrenia.  Although the sample in the current study was more diverse than most, 
little modification of ACT was necessary to achieve positive outcomes consistent with 
those observed in other studies.  Rosen and Davison (2003) argue that future outcome 
research should pay more attention to defining empirically-supported principles of 
change in contrast to trademarked treatment packages for every different disorder.  ACT 
may prove particularly useful in this pursuit, as the treatment emphasizes theoretically 
and empirically-derived principles of behavioral change that can be adapted easily to treat 
various conditions. 
The United Kingdom’s National Institute for Treatment Excellence (2002) 
guidelines for the treatment of schizophrenia lists CBT as one empirically-supported 
psychotherapy.  However, in the US, results of a recent study by the American 
Psychiatric Association’s Practice Research Network showed that individuals in 
Medicaid or Medicare programs and those over 65 rarely receive any psychosocial 
interventions in addition to medication for the treatment of schizophrenia.  Overall, only 
21 percent of the 151 adults with schizophrenia studied were receiving a CBT-type 
intervention (Moran, 2003).  The current study suggests that mindfulness/acceptance-
based CBT approaches are promising.  Future research comparing specific components 
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and investigating possible mechanisms of action in the wide range of cognitive-
behavioral approaches for psychosis is greatly needed to expand our knowledge base and 
to inform clinical practice with this patient population. 
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Table 1:  CBT for Psychotic Disorders Pilot Study:  Means (Standard Deviations) 
and Significant Differences for Self Report Measures 
 
 
Measures 
 
Pre-Treatment 
 
Post-Treatment 
 
z 
 
p 
 
 
BDI 
 
22.0 (7.5) 
 
12.6 (8.4) 
 
1.83 
 
    .07** 
 
SDS 
 
18.4 (2.5) 
 
13.4 (4.1) 
 
2.02 
 
  .04* 
 
ATQ 
     Believability 
     Frequency 
 
 
 
93.2 (33.1) 
90.2 (24.5) 
 
 
64.8 (31.3) 
83.2 (60.0) 
 
 
2.02 
0.41 
 
 
  .04* 
.69 
 
Note.  Data taken from Gaudiano et al. (2001). *p < .05; **p < .10.  BDI = Beck 
Depression Inventory; SDS = Sheehan Disability Scale; ATQ = Automatic Thoughts 
Questionnaire Believability and Frequency Subscales. 
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Table 2:  Assessment Schedule for Current Study 
 
 
Measure 
 
Pre-Treatment 
 
Post-Treatment 
 
Follow-Up 
 
 
BPRS 
 
 
X 
 
X 
 
SDS 
 
X X  
Psychotic Symptoms 
Self-Ratings 
     Frequency 
     Distress 
     Believability 
 
 
 
X 
X 
X 
 
 
X 
X 
X 
 
CGI 
     Severity 
     Improvement 
 
 
X 
 
 
X 
X 
 
Rehospitalization Data 
 
  X 
 
Note.  BPRS = Brief Psychiatric Rating Scale; SDS = Sheehan Disability Scale; CGI = 
Clinical Global Impressions Scales. 
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Table 3:  Demographic Characteristics of the Sample 
 
 
Characteristic 
 
Total Sample 
(n = 42) 
 
 
ETAU 
(n = 21) 
 
ETAU + ACT 
(n = 21) 
 
Sex 
     Male 
     Female 
 
 
64% (27) 
36% (15) 
 
 
86% (18) 
14% (3) 
 
 
43% (9) 
57% (12) 
 
Race 
     African-American 
     Caucasian 
     Hispanic 
     Asian 
 
 
88% (37) 
7% (3) 
2% (1) 
2% (1) 
 
 
85% (18) 
5% (1) 
5% (1) 
5% (1) 
 
 
91% (19) 
9% (3) 
0% (0) 
0% (0) 
 
Education 
     Less than H.S. 
     Some H.S. 
     H.S. diploma/GED 
     Some college 
     Missing 
 
 
2% (1) 
33% (14) 
36% (15) 
17% (7) 
12% (5) 
 
 
6% (1) 
35% (6) 
41% (8) 
12% (2) 
 
 
0% (0) 
40% (8) 
35% (7) 
25% (5) 
 
Employment 
     Unemployed 
     Part-time 
     Full-time 
     Disability 
     Missing 
 
 
26% (11) 
5% (2) 
7% (3) 
60% (25) 
2% (1) 
 
 
30% (6) 
5% (1) 
10% (2) 
55% (11) 
 
 
24% (5) 
5% (1) 
5% (1) 
66% (14) 
 
Relationships 
     Single 
     Married 
     Divorced/separated 
     Widowed 
     Missing 
 
 
60% (25) 
12% (5) 
22% (9) 
5% (2) 
2% (1) 
 
 
85% (17) 
5% (1) 
5% (1) 
5% (1) 
 
 
38% (8) 
19% (4) 
38% (8) 
5% (1) 
 
Housing 
     Own/rent 
     Friends/family 
     Shelter/homeless 
 
 
12% (5) 
38% (16) 
29% (12) 
 
 
5% (1) 
32% (6) 
42% (8) 
 
 
19% (4) 
48% (10) 
19% (4) 
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Table 3 continued 
 
     Supervised 
     Missing 
 
 
17% (7) 
5% (2) 
 
 
21% (4) 
 
 
15% (3) 
 
Insurance 
     CBH 
     Private 
 
 
88% (37) 
12% (9) 
 
 
91% (19) 
9% (2) 
 
 
86% (18) 
14% (3) 
 
Primary Axis I 
Diagnosis 
     Psychotic Disorder* 
     Mood Disorder** 
 
 
 
60% (25) 
40% (17) 
 
 
 
67% (14) 
33% (7) 
 
 
 
52% (11) 
48% (10) 
 
Substance Use Disorder 
     Yes 
     No 
 
 
57% (24) 
42% (18) 
 
 
62% (13) 
38% (8) 
 
 
52% (11) 
48% (10) 
 
Major Medical 
Conditions 
     One or more 
     None 
     Missing 
 
 
 
82% (34) 
17% (7) 
2% (1) 
 
 
 
 
81% (17) 
19% (4) 
 
 
 
85% (18) 
15% (3) 
 
Note.  CBH = Community Behavioral Health.  Substance use disorder defined as alcohol 
abuse/dependence or other substance abuse/dependence.  * Depressive Disorder NOS (n = 
11), Major Depression with psychotic features (n = 9), and Bipolar Disorder with 
psychotic features (n = 2).  ** Psychosis NOS (n = 15), Schizoaffective Disorder (n = 13), 
and Schizophrenia (n = 10). 
 
 
 
70 
 
 
 
 
Table 4:  Means (Standard Deviations) of Pre- and Post-Treatment Measures for 
Completers Only and Intention to Treat Analyses 
 
  
Completers Only 
n = 29 
 
Intention to Treat 
n = 42 
 
 
Measures 
 
ETAU 
n = 15 
 
ETAU + ACT 
n = 14 
 
ETAU 
n = 21 
 
ETAU + ACT 
n = 21 
 
 
BPRS-Total 
     Pre 
     Post 
 
 
59.8 (7.2) 
46.7 (9.5) 
 
 
60.3 (9.1) 
41.9 (9.1) 
 
 
59.0 (8.0) 
50.0 (10.5) 
 
 
57.3 (9.0) 
45.0 (9.0) 
 
BPRS-TD 
     Pre 
     Post 
 
 
13.5 (5.0) 
10.9 (4.3) 
 
 
11.2 (4.2) 
7.7 (3.3) 
 
 
14.6 (5.2) 
12.7 (5.3) 
 
 
10.7 (3.8) 
8.4 (3.3) 
 
BPRS-Anergia 
     Pre 
     Post 
 
 
12.1 (4.7) 
8.5 (4.2) 
 
 
13.8 (4.3) 
8.6 (3.4) 
 
 
11.2 (5.0) 
8.7 (4.5) 
 
 
13.0 (4.5) 
9.5 (3.9) 
 
BPRS-Affect 
     Pre 
     Post 
 
 
23.9 (3.0) 
18.2 (5.3) 
 
 
25.7 (3.1) 
16.4 (4.5) 
 
 
21.9 (4.3) 
17.8 (4.7) 
 
 
24.3 (4.1) 
18.1 (5.1) 
 
BPRS-D 
     Pre 
     Post 
 
 
6.9 (2.4) 
5.7 (2.4) 
 
 
5.9 (2.8) 
5.5 (2.4) 
 
 
7.4 (2.7) 
6.6 (3.0) 
 
 
5.8 (2.5) 
5.6 (2.2) 
 
CGI-S 
     Pre 
     Post 
 
 
6.1 (0.3) 
4.7 (1.1) 
 
 
6.0 (0.4) 
4.1 (0.9) 
 
 
6.1 (0.2) 
5.1 (1.1) 
 
 
5.9 (0.4) 
4.7 (1.1) 
 
CGI-I 
     Post 
 
 
3.0 (1.2) 
 
 
2.3 (0.6) 
 
 
-- 
 
 
-- 
 
H-Frequency 
     Pre 
     Post 
 
 
4.6 (2.4) 
3.7 (2.3) 
 
 
5.5 (1.7) 
3.9 (2.3) 
 
 
4.6 (2.4) 
4.0 (2.3) 
 
 
5.1 (2.3) 
4.1 (2.4) 
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Table 4 continued 
 
H-Distress 
     Pre 
     Post 
 
 
 
6.2 (3.7) 
6.9 (3.2) 
 
 
 
8.3 (2.3) 
6.5 (3.3) 
 
 
 
5.9 (3.6) 
6.4 (3.4) 
 
 
 
7.6 (3.1) 
6.4 (3.6) 
 
H-Believability 
     Pre 
     Post 
 
 
7.2 (3.4) 
6.9 (3.6) 
 
 
7.6 (3.0) 
5.7 (3.8) 
 
 
7.1 (3.2) 
6.9 (3.3) 
 
 
7.0 (3.6) 
5.7 (4.0) 
 
SDS-Work 
     Pre 
     Post 
 
 
8.7 (2.0) 
7.2 (3.2) 
 
 
8.6 (1.6) 
6.3 (2.6) 
 
 
8.3 (2.2) 
7.1 (2.9) 
 
 
8.9 (1.4) 
7.3 (2.7) 
 
SDS-Social 
     Pre 
     Post 
 
 
7.7 (2.5) 
7.6 (2.7) 
 
 
8.9 (1.5) 
6.5 (2.9) 
 
 
7.1 (3.3) 
7.0 (3.4) 
 
 
8.5 (2.5) 
6.9 (3.2) 
 
SDS-Family 
     Pre 
     Post 
 
 
 
8.8 (1.3) 
7.2 (2.7) 
 
 
 
8.9 (2.3) 
6.9 (2.6) 
 
 
 
8.4 (2.1) 
7.2 (2.8) 
 
 
8.6 (2.8) 
7.2 (2.9) 
 
Note. ETAU = Enhanced Treatment as Usual; ACT = Acceptance and Commitment 
Therapy; BPRS = Brief Psychiatric Rating Scale; BPRS-TD = thinking disturbance 
subscale; BPRS-D = disorganization subscale; H-Frequency = self-reported frequency of 
hallucinations; H-Distress = self-reported distress from hallucinations; H-Believability = 
self-reported believability in hallucinations; CGI = Clinical Global Impressions Scales; 
CGI-S = severity rating; CGI-I = improvement rating; SDS = Sheehan Disability Scale, 
SDS-Work = work subscale; SDS-Social = social subscale; SDS-Family = family 
subscale. 
 
 
72 
 
 
 
 
Table 5:  Effect Size Changes (Cohen’s d) on the BPRS Total and Thinking 
Disturbance Subscale Over Time and Between Groups for Completers Only* 
 
 
Time Point 
 
 
ETAU 
 
ETAU + ACT 
 
(ETAU + ACT) - ETAU 
 
Pre to Post (Within) 
     BPRS-Total 
     BPRS-TD 
 
 
1.40 
0.78 
 
 
1.67 
0.85 
 
 
-- 
-- 
 
Post (Between) 
     BPRS-Total 
     BPRS-TD 
 
 
 
-- 
-- 
 
 
-- 
-- 
 
 
0.41 
0.45 
 
Note.  ETAU = Enhanced Treatment as Usual; ACT = Acceptance and Commitment 
Therapy; BPRS = Brief Psychiatric Rating Scale; BPRS-TD = Thinking Disturbance 
Subscale.* The between group comparisons were calculated based on adjusted means. 
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Table 6:  Hierarchical Multiple Regression Analysis Predicting Change in Distress 
about Hallucinations Entering Change in Frequency of Hallucinations First and 
Change in Believability of Hallucinations Second in the ACT Group 
 
  
Coefficients 
 
  
 
Variables 
 
 
Unstandardized 
 
Standardized 
 
t 
 
p 
 
1. Frequency 
 
.43 
 
0.35 
 
2.08 
 
.062 
 
2. Believability 
 
 
.52 
 
0.76 
 
4.54 
 
.001 
 
Note.  Final Model:  F2, 11 = 12.41, p < .01, R2 = 0.69.  Frequency = self-reported 
frequency of hallucinations; Believability = self-reported believability of hallucinations. 
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Table 7:  Comparison of the Current Study and Bach and Hayes (2002) 
 
 
Characteristics 
 
Bach & Hayes 
 
Current Study 
 
 
Sample 
     Race 
     Female 
     Primary psychotic disorder 
     Comorbid SUD 
     Total size 
 
 
75% Caucasian 
36% 
75% 
19% 
80 
 
 
88% African-American 
36% 
60% 
57% 
42 
 
ACT 
     Format 
     Length 
     Timing 
 
 
Individual 
4 sessions 
Inpatient to outpatient 
 
 
Individual 
Variable (M = 3) 
Inpatient only 
 
TAU 
 
Treatment as usual 
 
Enhanced TAU 
 
Measures 
     Self-ratings of symptoms 
     Other self-report 
     Clinician-ratings 
 
 
Yes 
No 
No 
 
 
Yes 
Yes 
Yes 
 
Results 
     Hallucinations-Frequency 
     Hallucinations-Believability 
     Hallucinations-Distress 
     Clinically significant gains     
     Affective symptoms 
     Social impairment 
     Follow-up rehospitalization  
 
 
Pre to Follow-Up 
ACT > TAU 
ACT < TAU 
ACT = TAU 
N/A  
N/A 
N/A 
ACT = 50% reduction 
 
 
Pre to Post 
ACT = ETAU 
ACT < ETAU 
ACT < ETAU 
ACT > ETAU 
ACT < ETAU 
ACT < ETAU 
ACT = 38% reduction 
 
Note.  TAU = Treatment as Usual; ACT = Acceptance and Commitment Therapy; SUD = 
Substance Use Disorder. 
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Figure 1:  Participant Flow Diagram for Study Phases 
Randomized
(n = 42) 
Excluded (n = 18) 
     Refused to participate (n = 15) 
     Did not meet criteria (n = 3) 
Allocated to ETAU+ ACT  
(n = 21) 
     Completed treatment (n = 18) 
     Did not start (n = 2) 
     Drop out (n = 1) 
Allocated to ETAU  
(n = 21) 
     Completed treatment (n = 20) 
     Did not start (n = 0) 
     Drop out (n = 1) 
Post-Treatment (n = 18) 
     Incomplete data (n = 4) 
     Data analyzed (n = 14) 
Post-Treatment (n = 20) 
     Incomplete data (n = 5) 
     Data analyzed (n = 15) 
Follow-Up (n = 18) 
     Missing data (n = 0) 
     Data analyzed (n = 18) 
      
Follow-Up (n = 20) 
     Missing data (n = 0) 
     Data analyzed (n = 20) 
      
Assessed for 
eligibility (n = 60) 
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Note.  Pre-treatment scores used as covariate. 
 
 
 
Figure 2:  Group Differences on the Brief Psychiatric Rating Scale Affect Subscale 
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Figure 3:  Group Differences on Self-Reported Distress about Hallucinations 
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Figure 4:  Group Differences on the Sheehan Disability Scale Social Subscale 
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Note.  Clinically significant change defined as 2 standard deviation improvement pre- to 
post-treatment. 
 
 
 
Figure 5: Clinically Significant Change on the Brief Psychiatric Rating Scale Total 
Score and Thinking Disturbance Subscale at Post-Treatment 
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APPENDIX A:  SELF-REPORT RATINGS OF PSYCHOTIC SYMPTOMS5 
 
 
 
Instructions:  Read the questions and record the participants’ responses to the following 
based on assessment of psychotic symptoms. 
 
FREQUENCY 
1.  On average, how often have you heard voices [or seen X (hallucination); or thought 
about X (delusion)] in the past month [or since treatment started]?  
 
(1) Never 
(2) less than once a week 
(3) about once a week 
(4) several times a week 
(5) daily 
(6) more than once a day 
(7) almost constant   
 
 1a.  Hallucinations _____   1b.  Delusions  _____ 
 
DISTRESS 
2.  On a scale from 0 to 10, how bothered are you when you hear voices [or see X 
(hallucination); or think about X (delusion)]?  Zero means not distressed at all and 10 
means the most distressed you’ve ever been. 
 
 0 1 2 3 4 5 6 7 8 9 10 
 / / / / / / / / / / / 
Not bothered             Most bothered 
at all         you’ve ever been 
             
 2a.  Hallucinations _____   2b.  Delusions  _____ 
 
BELIEVABILITY 
3.  On a scale from 0 to 10, how much do you believe that when you hear voices [or when 
you see X (hallucination); or when your think about X (delusion)] that they are real [or 
that it is true (for delusion)]?  Zero means that you are certain it is not real or true, and 10 
means you are absolutely certain that it is real or true. 
 
 0 1 2 3 4 5 6 7 8 9 10 
 / / / / / / / / / / / 
Certain not             Certain 
real or true         real or true 
 
 3a.  Hallucinations _____   3b.  Delusions  _____ 
                                                 
5 Adapted from Bach and Hayes (2002). 
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APPENDIX B:  THE TREATMENT OF PSYCHOTIC DISORDERS WITH 
ACCEPTANCE AND COMMITMENT THERAPY  
IN AN INPATIENT SETTING6 
 
 
 
I. Background 
 Although the development of the newer atypical neuroleptics has produced 
considerable advancements in the treatment of psychotic disorders, many patients 
continue to experience both positive and negative symptoms even when medication 
compliance is not an issue.  Therefore, psychosocial treatments with substantiated 
efficacy and effectiveness that can be used in conjunction with pharmacotherapy are 
greatly needed.  Studies have demonstrated that cognitive behavior therapy (CBT) can be 
successfully adapted for treating psychotic disorders, including schizophrenia (Beck & 
Rector, 2000; Gould et al., 2001).  Furthermore, data suggest that CBT may prove more 
efficacious than supportive psychotherapy for schizophrenia (Tarrier, et al., 1998; Sensky 
et al., 2000).  Shortcomings in the CBT literature to date include a paucity of studies 
focusing on effectiveness issues, inpatient samples, and group interventions.   
 Emerging findings suggest that the incorporation of mindfulness-based techniques 
can be effective in reducing rehospitalization rates for this population (Bach & Hayes, 
2002).  CBT techniques traditionally have been focused on the active disputation and 
modification of dysfunctional beliefs to decrease their frequency, intensity, and 
believability.  Newer mindfulness/acceptance-based approaches, such as Acceptance and 
Commitment Therapy (ACT), target psychotic symptoms without directly seeking to 
change their content.  The ACT model proposes that psychopathology arises from 
“fusion” with cognitions and resultant experiential avoidance that hinders goal 
                                                 
6 Adapted from the treatment manual by Hayes et al. (1999) and Bach and Hayes (2002). 
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attainment.  Patients are taught to abandon control-oriented strategies and instead to 
experience private events (e.g., uncomfortable thoughts, feelings, and sensations) as such, 
without necessarily changing their content or “buying into” their literal truth.  This stance 
is achieved primarily through the use of mindfulness exercises and is presented in the 
context of goal-setting, values clarification, and overt behavior change (Hayes, et al., 
1999).   
Some suggest that mindfulness-based CBT may have specific advantages over 
disputation-based CBT (Teasdale et al., 2002).  Furthermore, researchers have warned 
that when using CBT with patients experiencing psychosis it is important first to build a 
strong therapeutic alliance, and then keep disputation to a minimum when engaging in 
cognitive restructuring (i.e., identifying and modifying distortions in thinking) (Kingdon 
& Turkington, 1994).  Providing some empirical support for this suggestion, Milton et al. 
(1978) found that the use of disputation techniques resulted in poorer treatment outcome.  
However with mindfulness-based CBT, the emphasis is not on disputing the literal 
content or validity of specific delusions or hallucinations, which can inadvertently result 
in alienating patients from treatment.  Instead, patients practice experiential exercises to 
help them defuse from their thoughts, so that they no longer associate private events (e.g., 
thoughts, feelings, bodily sensations) with “reality.”  Furthermore, patients are taught 
how to accomplish the goals that they set for themselves (according to their personal 
values) without getting side-tracked by psychotic symptoms.   
II. Overview of Treatment 
The treatment described below is based on guidelines developed by Hayes et al. 
(1999) and Bach & Hayes (2002).  It is assumed that therapists have read these texts 
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before conducting the treatment described below.  The ACT sessions are meant to be 
delivered in a typical inpatient psychiatric setting.  Therefore, the sessions are delivered 
in an “ongoing” format and patients can participate in the treatment as their stay dictates.  
Also, the treatment can be delivered in group or individual formats.  Each 1-hour session 
contains a core set of components that permits patients to enter or leave treatment during 
their stay on the unit without difficulty.  First, a psychoeducational component can be 
presented based on the patients’ relevant symptoms.  Then, the ACT model is presented 
to provide a rationale for treatment.  Next, various mindfulness and acceptance exercises 
are practiced to help patients move away from attempts to avoid and catastrophize 
symptoms.  Instead, patients are taught ways of accepting and experiencing symptoms 
without allowing them to interfere with goal-directed behavior.  In this way, patients 
decrease their tendency to interpret psychotic symptoms as representing reality, similar to 
in other CBT approaches.  Next, goals and valued behaviors are elicited from patients, 
and the role of disturbing thoughts/emotions as barriers to goal attainment is discussed.  
Each session ends with a review and suggestions for practice exercises to attempt 
between sessions.  Because of the possible cognitive limitations of patients with 
psychotic disorders, therapists should rely mainly on analogies and experiential exercises 
to explain the concepts and refrain from over-intellectualizing the discussion.  
Furthermore, although specific mindfulness metaphors and exercises are identified 
below, they can be substituted for others that address similar themes.  Metaphors that 
resonate with patients in a particular session can be used more frequently if appropriate.  
If time is an issue, spend less time on the psycho-educational piece but integrate it into 
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the discussion of other topics.  Finally, it is important that therapists present ACT 
terminology and concepts in a manner appropriate for the particular patient being treated. 
III. Outline of Sessions  
A. Session A  
1.  Review homework.  Some patients will be new to the treatment while others 
will have had previous sessions.  At the start of each session, some time (approximately 5 
minutes) should be spent eliciting feedback from patients who attempted practice 
exercises between sessions.  Compliance with homework should be encouraged but 
noncompliance should only be noted.  A punitive stance should not be taken with those 
who do not complete the assignments.  Reviewing homework provides an introduction to 
new patients if conducted in a group format, sets the tone, and highlights potential 
successes the other patients have achieved.  Previously, patients were asked to practice 
using the FEAR and ACT algorithm cards (see Session D).  Solicit feedback about the 
exercise, stressing the importance of practice and behavioral consistency. 
2.  Psychoeducation.  Frank and open discussion of patients’ symptoms can help 
to normalize their experience.  Also, educating patients about the nature of their 
symptoms can help them to develop a broader perspective on their experiences, so that 
they attribute them less as personal faults or weaknesses.  How buying into psychotic 
symptoms impedes goal attainment should be emphasized throughout the discussion. 
Hallucinations are seeing, hearing, smelling, or feeling things that others can’t 
see, hear, smell or feel.  Dreams are like daily “hallucinations.”  Hallucinations can take 
“scary” forms and keep patients from doing what they set out to do.  For example, they 
may be distracted and have difficulty focusing during session because they hear voices 
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that other members don’t.  Delusions make it difficult for patients to separate thoughts 
from reality.  They are beliefs that most other people do not hold.  Such beliefs also can 
keep people from doing the things they want to do.  For example, someone afraid that 
others are trying to hurt them may be unwilling to go to work.  Thoughts may or may not 
be true.  For example, everybody used to believe that the earth was flat.  However, even 
if everyone on the world believed the earth was flat, it didn’t make it so. 
3.  The ACT model.  Explore previous approaches to coping with symptoms of 
psychosis.  Discuss the futility of attempts to control unwanted thoughts.  Describe the 
Polygraph Metaphor  (pp. 123-124)7.  This metaphor illustrates the futility of trying to 
control internal states.  Introduce the concepts of acceptance and willingness.  
Willingness is an action not a feeling.  It is experiencing something as it is, not as what it 
says it is.  Discuss the option of just noticing thoughts rather than believing and acting on 
them as an alterative coping strategy that patients may not have explored up to this point.   
4.  Mindfulness exercise.  Conduct the Clouds in the Sky Exercise (also, Soldiers 
in the Parade Exercise, pp. 159-160).  This helps clients practice experiencing thoughts 
and emotions as such, while developing stable sense of self. 
5.  Values and goals.  Values are what we want our lives to stand for.  Values are 
not feelings but choices.  Everyone possesses the ability to define a life direction.  Elicit 
values from patients in areas such as intimate relationships, family relations, social 
relations, employment, education and training, recreation, spirituality, heath, etc.  For 
example, “I value…being a supportive parent to my children.”  Help patients separate 
                                                 
7 Page numbers listed correspond to Hayes et al. (1999). 
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what they value from what they believe they can accomplish.  In other words, help 
patients to separate their values from perceived obstacles.  
 Goals are the concrete steps we take to work on values.  They are like each step 
you take on a long journey.  In contrast, values are abstract ideals that can never be fully 
attained.  Elicit example goals that patients formulate based on their values.  Introduce 
the concept that working toward something is the definition of success.  Success is not 
necessarily the final result of that action.  In other words, make the process the goal.  
Describe the Skiing Metaphor (pp. 220-221).  This illustrates how most of the reward is 
often in the process. 
 6.  Review session.  This population often possesses various types of cognitive 
limitations that may make it more difficult for them to understand and retain the 
information presented in sessions.  Therefore, it is important to highlight the important 
“take home messages” that were covered.  The use of a whiteboard can enhance this 
process.  Highlight the key concepts covered in the session, including the nature of 
psychotic symptoms, the negative effects of control, acceptance as an alternative, and the 
process as the goal.  
 7.  Assign homework.  Discuss with patients the importance of practicing the 
concepts covered between sessions.  Stress that many of the things presented are skills, 
like riding a bike that can only be improved through practice.  Stress that the process is 
the only outcome that they should seek, and simply attempting the assignment should be 
considered the “success.”  Tell patients if they run into any problems that they should 
note them and report on them at the beginning of the following session.  Suggest that 
patients practice the Clouds in the Sky Exercise twice daily for 5 to 10 minutes each.   
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B. Session B 
1.  Review homework.  Instruct patients that it was perfectly normal if their minds 
wandered during the exercise.  Tell them that if their mind wanders a thousand times, 
their only job is to bring it back a thousand times.  If they report that they became 
frustrated with the exercise or saw scary images, ask them if they are able to put that 
thought on a cloud and allow it to float by. 
2.  Psychoeducation.  It is important for patients to understand that psychotic 
symptoms reside on the continuum of “normal” experience.  Many people experience 
psychotic symptoms at some point in their life and they can be caused in virtually anyone 
through sleep deprivation, sensory deprivation, certain drugs, or medical complications.  
In some ways they can be viewed as the mind’s misinterpretations.  For example, ask 
patients to relate to the experience of a child seeing shapes in the dark and being scared.  
Also, many adults are superstitious or believe in supernatural powers.  It is not the 
symptoms per se that are the problem, but if they interfere with the person’s ability to 
pursue valued goals. 
 3.  The ACT model.  Introduce the concept of workability.  Elicit specific 
symptoms in detail and how distressing they are.  Discuss how trying to control 
symptoms has or has not worked in the past.  If it did seem to work, for how long?  
Describe Tug of War with a Monster Metaphor (p. 109).  This illustrates how trying to 
control the problem often only makes it worse.  Discuss “letting go” of the struggle with 
private events by “dropping the rope.”  Encourage patients to accept their symptoms as 
an experience even though they may not like them.  Clarify that they are not to accept 
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what the symptoms necessarily represent themselves to be but simply their experience of 
them. 
 4.  Mindfulness exercise.  Conduct the Contents on Cards Exercise (p. 162).  
Provide patients with index cards and have them write on them their most distressing 
thoughts, feelings, or symptoms.  Have them carry their cards with them while they 
perform an activity such as a role play (e.g., talking to their doctor).  Have clients carry 
the cards with them until the next session for homework. 
 5.  Values and goals.  Review the concepts of values and goals.  Elicit examples 
from patients.  Sometimes patients have difficulty with commitment toward valued goals.  
Describe the Gardening Metaphor (p. 220).  This illustrates staying the course in the face 
of uncertainty. 
 6.  Review session.  Highlight the key concepts of the session, including the 
continuum of “normal” experience, the concept of workability as the guide, the ability to 
take action despite uncomfortable symptoms, and commitment toward goals. 
 7.  Assign homework.  Have patients practice carrying their index cards with 
distressing content on them with them as they do their daily activities.  Ask them to bring 
the cards to the next session.   
C. Session C 
1.  Review homework.  Ask patients to produce their content cards.  Note any 
changes in reaction that patients have to the cards.  Solicit feedback about the exercise. 
 2.  Psychoeducation.  Discuss how life events affect symptoms.  Discuss the 
diathesis-stress model of psychosis, suggesting a vulnerability that is triggered by stress 
in some people.  Contrast this with the previous discussion of psychosis being on the 
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continuum of “normal” experience that can be induced by “everyday stressors” such as 
sleep deprivation.  Help clients to identify potential stressors that will be occurring in the 
near future and how they can respond to them.     
 3.  The ACT model.  Introduce the difference between “dirty” versus “clean” 
discomfort.  Clean discomfort is distress that is produced because of the actual stressor.  
Dirty discomfort is when one is distressed about being distressed.  Dirty discomfort 
comes from unwillingness.  Elicit examples from patients.  For example, hallucinations 
or delusions are distressing; however, much of the negative effects of these symptoms 
come from being distressed about having them in the first place.  Discuss letting go of the 
struggle as an alternate strategy that does not add dirty discomfort.   
 4.  Mindfulness exercise.  Conduct the “I Can’t Do This” Exercise.  In this 
exercise, patients are asked to say something that they “can’t” do aloud repeatedly while 
doing it.  This illustrates how patients can accomplish goals even though their 
minds/hallucinations say they can’t.   
 5.  Values and goals.  Review the concepts of values and goals.  Elicit examples 
from patients.  Describe the Path Up the Mountain Metaphor (p. 222).  This illustrates 
how to remain committed to goals and look at “success” from a broader perspective. 
 6.  Review session.  Highlight the important concepts covered, including how 
stress impacts symptoms, dirty versus clean discomfort, how thoughts and words affect 
our behavior, and commitment in the face of uncertainty. 
 7.  Assign homework.  Ask patients do define one goal each day that they attempt 
even if their “minds” tell them they can’t do it.  The goal does not have to be something 
big, just as long as it is consistent with their values. 
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D. Session D 
1.  Review homework.  Review the homework exercise of completing a mini-goal 
patients set for themselves even if their minds told them they couldn’t do it.   
2.  Psychoeducation.  Discuss medication compliance as an issue of workability 
that allows other goals to be pursued.  Elicit obstacles to medication compliance and 
discuss unwelcome side effects.  Describe and elicit examples of the benefits of 
medication.   
3.  The ACT model.  Discuss the concept of self as being different from thoughts 
and feelings by describing the Chessboard Metaphor (p. 190).  Use an actual 
chess/checkers board and items to represent mental content.  This helps patients to 
separate their stable sense of self from their experience.   
4.  Mindfulness exercise.  Give patients the FEAR and ACT algorithm cards (p. 
245).  Help patients to identify when they are acting out of Fusion with thoughts, 
Evaluation of experience, Avoidance of experience, and Reason giving for behavior and 
instead to Accept reactions and be present, Choose a valued direction, and Take action.  
Elicit examples from patients. 
5.  Values and goals.  Review values and goals.  Elicit examples from patients.  
Discuss how obstacles can impede goal attainment.  The Swamp Metaphor (p. 248) can 
be alluded to here if appropriate.  This illustrates that patients are willing to experience 
distress because it is in the service of something they value.   
6.  Review session.  Review the central themes of the session, including the 
importance of medication compliance, the difference between self and thoughts, and how 
to deal with obstacles in the pursuit of goal attainment. 
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7.  Assign homework.  Ask patients to practice using the FEAR and ACT 
algorithms. 
IV. Therapist Considerations 
 Although ACT shares many similarities with traditional CBT approaches (e.g., 
present-focused, collaborative, time-limited, focused on definable goals, etc.), it also has 
differences.  For example, therapists are asked to be just as “willing” as patients to 
experience uncomfortable private events.  If patients discuss distressing symptoms they 
are having, most therapists do what they can to “fix” them.  However in ACT, the focus 
is not at the level of content.  Therapists encourage patients to practice “sitting with” 
discomfort and to focus instead on changing the patient’s relationship to their experience, 
not the experience itself.   
 Also, ACT therapists must be careful not to “push” values upon patients.  Patients 
are assumed to be fully capable of defining their own values and goals.  The principle 
tenet of ACT is functionality and workability.  It is the therapist’s job to help patients 
separate their values from the perceived obstacles that impede their progress.  Often, 
patients change their values based on their obstacles.  In ACT, patients are encouraged to 
define their values, work toward them, and work through any obstacles.   
 Finally, ACT is not an intellectual enterprise, it is an experiential one.  Therapists 
must be careful not to fall into the trap of trying to convince patients, as can be the pitfall 
of other cognitive approaches.  Most importantly, therapists should present an accepting 
stance in the face of uncertainty, confusion, distress, and disagreement.   
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